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Der Mensch hat nicht das Recht über Tiere zu urteilen, 
sie stammen aus einer anderen Welt, 
die älter und vollständiger war als unsere jetzt, 
ihre Erscheinung ist besser und vollständiger, 
sie haben Eigenschaften, 
die wir verloren oder nie erreicht haben… 
sie sind keine Untertanen, 
sie gehören einer anderen Nation an 
-und sind nur durch Zufall mit uns zugleich 
ins Netz der Zeit gefallen, die wir Glanz 
und Plage zugleich für die Erde sind. 
                                                              Beston Henry 
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I. INTRODUCTION 
Different substances such as hormones, cytokines or growth factors play an 
important role during tissue homeostasis and in the regulation of most cellular 
functions. The classical hormones are transported by the blood system over long 
distances until they reach their target. Cytokines are expressed in nearly every 
tissue and have mostly a local effect. Growth factors have a position in between: 
They are expressed in almost every tissue and can also act over long distances. 
Some growth factors are expressed as membrane bound precursors on the cell 
surface and can interact with the extracellular domain of receptors like receptor 
tyrosine kinase (RTK). They can activate cell surface receptors to induce signal 
transduction cascades and thereby regulate gene expression, cell differentiation, 
cell metabolism, apoptosis and proliferation (Massague, 1993). 
The Epidermal Growth Factor Receptor family is one of the most important 
receptor families and includes four receptors: ERBB1 (EGFR, HER1), ERBB2 
(HER2, neu), ERBB3 (HER3) and ERBB4 (HER4). These receptors are 
expressed in several tissues and can regulate different physiological and 
pathological processes (Yarden, 2001), including cancer development (Pinkas-
Kramarski, 1998). The ERBB receptors can be activated by eleven different 
ligands. These ligands can be receptor-specific or activate several receptors of the 
ERBB family (Holbro, 2003). 
The ERBB receptors play a role in inflammation processes (Scheller, 2011) such 
as acute pancreatitis (AP), an inflammatory disease of the exocrine part of the 
pancreas. AP is characterized by acute abdominal pain in the epigastric area and 
increased serum levels of pancreatic enzymes such as amylase and lipase. 
Gallstone migration and alcohol consumption are the most common causes of 
acute pancreatitis. Fortunately, the mortality rate is lower than 5%. However, the 
risk to develop severe disease is about 20%. Organ failure associated with 
circulatory disorder in the early stage and infectious complications, such as 
infected pancreatic necrosis in the late stage are the main reasons for the mortality 
of pancreatitis patients (Matsumoto, 2014). AP seems to be caused by a regulation 
defect of trypsinogen, leading to cell death and the rise of pancreatic enzymes in 
the blood (Nemeth, 2013). 
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Betacellulin (BTC), a ligand of EGFR and ERBB4, has a protective effect against 
AP (Dahlhoff, 2010). ERBB4 is predominantly expressed in the exocrine part of 
the pancreas, and the EGFR in the endocrine pancreas. In this study we 
investigated whether the BTC-mediated protection against AP is mediated by 
EGFR or ERBB4.  
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II. REVIEW OF THE LITERATURE 
1. The Epidermal Growth Factor Receptor family 
All ERBB family members have an extracellular domain, followed by a single 
membrane-spanning region and a cytoplasmic domain (Olayioye, 2000). Receptor 
binding initiates dimerization of homo- and heterodimers and this formation leads 
to an autophosphorylation of specific tyrosine residues in the cytoplasmic domain. 
This process is followed by a complex cascade of downstream signalling 
pathways which are responsible for numerous effects affecting development, 
physiology, and pathology (Holbro, 2003), (Yarden, 2001). The ERBB2 receptor 
has no known ligand and the ERBB3 receptor does not contain an active tyrosine 
kinase (Linggi, 2006). Each receptor, with its unique signalling properties, can be 
specifically activated by its ligands (Beerli, 1996), (Sweeney, 2000). However, 
only the EGFR and the ERBB4 receptor can be activated as homodimer. Eleven 
different growth factors have the ability to bind and activate the ERBB receptors. 
Based on their binding specifity, the ligands can be divided into three groups: The 
first group includes epidermal growth factor (EGF) itself, transforming growth 
factor-α (TGFA), epigen (EPGN) and amphiregulin (AREG), which can activate 
only EGFR. The second group includes heparin-binding EGF-like growth factor 
(HBEGF), epiregulin (EREG), and betacellulin (BTC). These ligands have the 
skills to bind both the EGFR and the ERBB4 receptor. The neuregulins represent 
the third group. They can be divided into two subgroups based on their capacity to 
bind only ERBB4 or ERBB3 and ERBB4 (Holbro, 2003), (Harris, 2003). In 
addition, BTC and EGF can activate the ERBB2/ERBB3 heterodimer. The ERBB 
ligands are mainly synthesized as a transmembrane type I protein that can be 
cleaved by cell surface proteases to release the mature growth factor as a soluble 
form. All these ligands include a domain encompassing about 50 amino acids and 
possessing six characteristically spaced cysteines which form three intramolecular 
disulfide bonds leading to a three loop secondary structure. This sequence (called 
the EGF motif) is the precondition for ERBB receptor binding and activation 
(Harris, 2003),(Schneider, 2009).  
 
The EGFR elicit manifold actions during development in adult mammals. HBEGF 
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is the only ligand whose absence results in postnatal lethality, due to malformed 
heart valves, hypertrophic cardiomyocytes, and hypoplastic lungs (Jackson, 2003) 
while mice lacking EGF (Luetteke, 1999), EREG ((Lee, 2004); (Shirasawa, 
2004), AREG (Luetteke, 1999), BTC (Jackson, 2003), TGFA (Luetteke, 1993), 
and even triple null mice deficient for EGF, AREG and TGFA (Luetteke, 1999) 
are viable. These observations clearly signify that there is a high rate of 
redundancy within the family of EGFR ligands (Qin, 2005). 
Signalling by activated ERBB receptors includes the following pathways: mitogen 
activated protein kinase (MAPK), phospholipase Cγ, signal transducer and 
activation of transcription (STAT), protein kinase B (PKB/AKT) and stress 
activated protein kinase (SAPK), which are common to nearly all RTKs. 
Activated ERBB receptors are processed from the cell surface by an endocytotic 
pathway resulting in rapid receptor degradation. Related to the intracellular 
migration of ERBB receptors, each of these receptors has been reported to be 
present in the nucleus. Relocalization of the EGFR and the ERBB4 receptor is a 
ligand-dependent process which can also influence gene expression and might 
represent a new signalling mechanism (Linggi, 2006).  
 
2. ERBB4 expression and signalling 
ERBB4, a glycoprotein of 180 kDa (Plowman, 1993), can be detected like all 
ERBB receptors in almost every tissue and is known to play an important role in 
the development of neuronal tissue, the heart and the mammary gland (Jones, 
2003). The ERBB4 receptor has been also detected in neoplastic tissue like 
neoplastic thyroid, medulloblastoma, and neoplastic prostate (Srinivasan, 1998). 
Its role in the development of the pancreas, and in AP, is still unknown 
(Veikkolainen, 2012). The presumed role of ERBB4 in the development of the 
exocrine pancreas and AP in interaction with its ligand BTC, which protects mice 
against AP, is based on the finding that ERBB4 is predominantly expressed in the 
exocrine part of the pancreas (Dahlhoff, 2010),(Kritzik, 2000), (Huotari, 2002) 
and has been shown to have proapoptotic properties (Sartor, 2001), (Vidal, 2005), 
(Naresh, 2006). 
The role of ERBB4 in other inflammation processes, described in multiple 
 II. Review of the literature     5 
publications, includes lung inflammation (Purevdorj, 2008) and Crohn’s colitis, 
where ERBB4 is believed to promote cell survival and replacement after injury or 
inflammation (Frey, 2009).  
The expression of ERBB4 starts at E9.5 (Gassmann, 1995). It is assumed that 
ERBB4 receptor signalling shows a number of characteristic features. The stress 
activated protein kinase (SAPK) pathway might be initiated by BTC via ERBB4 
in AP, which seems to ensure a protective effect in AP due to an increased 
apoptosis induction (Dahlhoff, 2010). ERBB4 is expressed as alternatively spliced 
isoforms with different intracellular cytoplasmic (CYT) and extracellular 
juxtamembrane (JM) domains. By ligand activation the ERBB4 JM type a (JM-a) 
is cleaved and leads to a regulated intramembrane proteolysis (RIP) and an 
intracellular C-terminal domain is released (ICD) in the cytoplasm (Zeng, 2009). 
RIP was shown to be an alternative signalling pathway in ERBB4 signalling 
which leads to receptor proteolysis by TACE/ADAM17 and the release of the 
intracellular domain of ERBB4 in the cytoplasm (Rio, 2000), (Naresh, 2006). The 
disintegrin and metalloproteinase 17 (ADAM17), also called tumor necrosis 
factor-α converting enzyme (TACE), is a membrane-bound enzyme that cleaves 
ligands of ERBB receptors. The ectodomain shedding of these molecules can alter 
their biology and impact on immune and inflammatory responses and cancer 
development (Scheller, 2011). The 120 kDa ICD of ERBB4 can be either 
degraded through ubiquination or translocate to the nucleus to regulate gene 
expression and cell functions. Two ICD isoforms are known: CYT-1 and CYT-2. 
They differ at their cytoplasmic tails by including (CYT-1) or not (CYT-2) a 16-
amino acid stretch containing binding sites for phosphoinositide 3-kinase (PI3-K) 
(Kainulainen, 2000) (Elenius, 1999) and the WW domain-containing e.g. Nedd-
like ubiquitin ligases (Sundvall, 2008), (Zeng, 2009). 
Unlike to the EGFR which is degraded efficiently through endocytosis, little is 
known about ERBB4 receptor degradation. It could be shown that ERBB4 cannot 
be degraded through endocytosis but by ubiquination, a process where ubiquitin is 
conjugated to side chains of proteins (Zeng, 2009). 
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3. Betacellulin  
BTC was originally isolated from a mouse pancreatic β-tumor cell line as a 32-
kDa glycosylated protein (Shing, 1993). BTC is able to activate EGFR, ERBB4 
(Holbro, 2003) and all possible combinations of ERBB heterodimers, including 
the oncogenic ERBB2/3 heterodimer (Alimandi, 1997),(Pinkas-Kramarski, 1998). 
BTC can be found in almost every tissue and body fluids (Dunbar, 2000). Like 
other ERBB ligands, the expression of BTC can be upregulated upon receptor 
activation by BTC itself (auto-induction) or by other ERBB family members 
(cross-induction). This kind of regulation has been observed in rat intestinal 
epithelial cells, pancreatic cancer cell lines, human head and neck squamous 
carcinoma cells and human keratinocytes, suggesting an additional level of EGFR 
signal integration (Barnard, 1994),(Yokoyama, 1995),(Kawaguchi, 2000),(P, 
2000). 
In the mouse, the tissues with the highest endogenous BTC expression are the 
lung, the kidney, the uterus (Shing, 1993),(Ogata, 2005) and the pancreas, where 
BTC seems to play a role in islet regeneration (Li, 2001). BTC contains, like all 
ERBB ligands, the EGF motif and is synthesized as a transmembrane precursor. 
Proteolytic cleavage leads to the soluble and mature form of BTC. There is 74% 
identity between the human and the mouse BTC primary structure (Dunbar, 
2000). BTC displays some unique properties at the structural and functional level. 
In addition to the EGF motif, additional cysteines are found that might form a 
fourth disulfide bridge. BTC features an Arg-Gly-Asp (RGD) sequence, presumed 
to influence cell-cell interactions. In addition, a disintegrin and metalloprotease 10 
(ADAM10) was identified as the main shedding enzyme for BTC and EGF 
(Sahin, 2004).  
Endogenous BTC induces the expansion of progenitor populations of neural stem 
cells and neuroblasts in the mouse brain (Gomez-Gaviro, 2012). This effect is 
mediated by both EGFR and ERBB4. Furthermore, BTC affects cell proliferation, 
differentiation, and survival, when added to cultured cell lines (Dunbar, 2000). 
Mice lacking BTC expression are viable, fertile and show no overt defects 
(Jackson, 2003) in contrast to mice with ubiquitous BTC-overexpression (Btc 
transgenic mice) which show reduced body weight gain, a lung and eye pathology 
and also the pancreas weight is significantly reduced (Schneider, 2005). Acinar 
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apoptosis and proliferation is significantly increased in the pancreas of Btc 
transgenic animals. Moreover, the examination of the pancreas weight showed no 
difference between Btc transgenic mice and Btc transgenic mice with an additional 
hypomorphic mutation of the Egfr gene (Btc+Wa5). This observation indicates 
that the effects of BTC on the exocrine pancreas are EGFR-independent 
(Dahlhoff, 2010). 
In addition, mice overexpressing ubiquitously BTC are protected against 
caerulein-induced and L-arginine-induced pancreatitis, showing significantly 
decreased amylase and lipase levels, reduced acinar necrosis, inflammation and 
edema in pancreatitis experiments. The analysis of signalling pathways indicated 
a dependence of the protective effect on JNK / SAPK (Dahlhoff, 2010). 
 
4. Pancreas and acute pancreatitis 
4.1. Exocrine pancreas 
The pancreas is a retroperitoneal organ without a capsule. The pancreas contains a 
head, body, tail and the uncinate process. The second and third portion of the 
duodenum curves around the head of the pancreas. The pancreatic tail is adjacent 
to the spleen. The distal end of the common bile duct, which joins the pancreatic 
duct entering the duodenum, passes through the head of the pancreas. For this 
reason, pathologic processes of the pancreas can lead to biliary system obstruction 
and injury. There are also important relationships between the exocrine and the 
endocrine pancreas (islets of Langerhans). The blood from the endocrine pancreas 
flows directly in the capillaries of the exocrine tissue surrounding each of the 
islets before entering the general circulation. This special blood flow works as a 
kind of „portal“-system, protecting the surrounding tissue of the islets of high 
hormone concentrations (The exocrine pancreas, Stephen J.Pandol), 
(Untersuchungen über das Gefässystem des Pankreasläppchens bei verschiedenen 
Säugern mit besonderer Berücksichtigung der Kapillarknäuel der 
Langerhansschen Inseln, Annemarie Thiel, 1953). 
The islets of Langerhans produce the following hormones: insulin (β-cells), 
amylin, glucagon (α-cells), somatostatin (δ-cells) and pancreatic polypeptide (PP-
cells). The effect of these hormones on the exocrine pancreas is not known in 
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detail (Lazarow, 1957), (The exocrine pancreas, Stephen J.Pandol). The acinar 
cells for example have insulin receptors that are involved in the regulation of 
digestive enzyme synthesis. The functional unit of the exocrine pancreas consists 
of an acinus and its draining ductule. The acinus (from the Latin term meaning 
“berry in a cluster”) contains specialized acinar cells which are able to synthesize, 
store, and secrete digestive enzymes. On the basolateral membrane, receptors for 
different hormones and neurotransmitters are located. Activating these receptors 
stimulate the secretion of the digestive enzymes. The apical region of the cell 
accumulates zymogen granules and enzymes. Additionally there are microvilli on 
the apical surface of the acinar cells. Those microvilli, together with the 
cytoplasm, work as a filamentous actin meshwork, which is involved in 
exocytosis of the contents of the zymogen granules. There are tight junctions 
between acinar cells to form a barrier and prevent the passage of large molecules, 
such as the digestive enzymes. The junctional complexes also permit the 
paracellular passage of water and ions (The exocrine pancreas, Stephen J.Pandol). 
The pancreatic acinus and the large ducts seem to develop polyclonally by 
multiple progenitor cells. They might result from an assembly of small ducts 
developing from a single origin (Ryu, 2013). 
The ERBB receptors and their ligands are important for the development of the 
pancreas and the differentiation of the acinar cells. EGF for example is able to 
stimulate directly pancreas growth (Dembinski, 1982) and exocrine secretion 
(Konturek, 1984). It is also known that the ERBB receptors play a role in 
pancreatic adenocarcinoma and in chronic pancreatitis (te Velde, 2009) as well as 
in AP (Dahlhoff, 2010). 
 
4.2. Acute Pancreatitis in humans and in animal models 
AP is an inflammatory disease of the exocrine part of the pancreas. The yearly 
incidence of AP in the United States is approximately 32-44 new cases per 
100000 population individuals and has increased over the last decade. This 
increase in incidence has been observed worldwide. AP is the most common 
cause of gastrointestinal related hospitalizations, with more than 274000 
hospitalizations in 2012 (Tyler Stevens, 2009). AP is clinically manifested by 
abdominal pain and a concomitant rise in serum amylase and lipase. The most 
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common causes are alcohol abuse and gallstone migration. About 80% of the 
cases of AP run a benign course. Our knowledge about the pathology of AP is 
mainly based on animal studies. The inflammatory process starts in the acinar 
cells where zymogens and lysosomale granules are made fragile by substances 
such as alcohol and its metabolites. Substances released by the granules activate 
intracellular digestive enzymes, like trypsin (Vonlaufen, 2007). Because of the 
premature activation of these digestive enzymes the pancreatic tissue is 
autodigested, and leucocytes start to immigrate. Due to that autodigestion, the 
release of amylase and lipase in the blood can be detected as a biochemical 
marker for AP (Matull, 2006). The mortality rate is directly influences by the 
systemic inflammatory response syndrome (SIRS) (Schepers, 2013) and the 
infection of pancreatic necrosis (Muller, 2007). 
To get a better insight into the course of AP, several animal models of AP have 
been developed, mostly in rodents. It is important to mention that not all aspects 
of the human disease can be reproduced in the experimental models. Nevertheless 
there are experimental models which can reveal some important aspects of AP in 
humans. Intraperitoneal injections of caerulein cause a mild, self-limiting form of 
AP in mice. This model can be used to study the activation of signalling 
pathways, synthesis of cytokines and the alteration of the cytoskeleton during AP 
(Schmid, 2005). Caerulein causes AP through activation of chymotrypsinogen, 
what leads to an auto activation of trypsinogen (Nemeth, 2013). After three 
intraperitoneal injections of 50 µg/kg body weight, caerulein leads to a threefold 
increase of serum amylase, and an increase of pancreatic body weight of 34%. 
The highest levels of serum amylase and pancreatic body weight can be observed 
12 hours after starting the injections (Niederau, 1985). In the caerulein-induced 
pancreatitis the cell death is either initiated by necrosis or apoptosis. The severity 
of the pancreatitis correlates directly with the number of necrotic acinar cells and 
in inverse ratio with the number of apoptotic cells (Gukovskaya,2004).
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III. ANIMALS, MATERIAL AND METHODS 
1. Animals 
All mice were bred and handled under specific pathogen free conditions in a 
closed barrier system at 22°C, 65% humidity and a 12 h light cycle in the Gene 
Center, LMU Munich. All animals received standard food (V1536; Ssniff, Soest, 
Germany) and water ad libitum. At the age of four weeks the mice were weaned, 
separated by gender, marked by ear clipping and housed in Makrolon cages type 2 
or 3. At the same time tail tips for genotype analysis were taken and frozen by -
80°C. If phenotype studies started earlier, foot tattooing was used to identify the 
animals. All animal experiments were carried out in accordance with the German 
Animal Protection Law with permission from the responsible veterinary authority 
(AZ 55.2-1-542531-138-10). 
 
1.1. Conditional Erbb4 knockout mice 
Mice with a loss of function in the Erbb4 gene in all tissues die in utero between 
day 10 and 11 after fertilization (E10-11) due to heart muscle developmental 
abnormalities (Gassmann, 1995). Therefore we generated conditional Erbb4 
knockout mice (Erbb4-KO) for the exocrine pancreas using the Cre-loxP-system. 
In Ptf1atm1(cre)Hnak (Ptf1a-Cre) mice the Cre enzyme is expressed under the control of 
the pancreas-specific Ptf1a promoter (Nair, 2013), (Delaspre, 2013) Ptf1a-Cre 
mice were mated with B6;129-Erbb4tm1Fej/Mmucd (Erbb4fl/fl) mice to delete the 
loxP-flanked exon 2 of the Erbb4 gene. The resulting mRNA of the Erbb4 gene 
carries a frame shift. The Ptf1a tm1(cre)Hnak mice were kindly provided by Hana 
Algül, PD Dr. med (Klinikum rechts der Isar, Munich). The resulting Erbb4-KO 
mice stay alive and show no overt differences during their development compared 
to their wildtype littermates. 
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1.2. Egfr+/Wa5 mice 
Egfr+/Wa5 (Wa5) mice were generated by a N-ethyl-N-nitrosourea (ENU) 
mutagenesis program and are maintained in the C57BL/6N background (Lee, 
2004). These mice carry a mutation altering the highly conserved DFG motif 
within the activation loop of the Egfr kinase domain. This point mutation results 
in the expression of a dominant negative EGF-receptor. Homozygous embryos die 
during gestation while heterozygous Egfr+/Wa5 survive. They have opened eyes at 
birth, a wavy coat and an abnormal placental constitution. Wa5 mice are an 
accepted EGFR in vivo knockdown model as less than 10 % of the EGFR activity 
is maintained. 
 
1.3. Btc transgenic mice 
For our experiments we used the ubiquitous BTC-overexpressing mice pTORU-
Btc (Schneider, 2005). This transgenic mouse line was established by pronuclear 
DNA microinjection into zygotes. The mice show the highest BTC expression 
levels in the heart, lung, brain, and the pancreas. They exhibit high early postnatal 
mortality, reduced body weight gain, and impaired longitudinal growth. Cataract 
and abnormally shaped retinal layers as well as bone alterations leading to a 
dome-shaped, round head form were also observed in Btc transgenic mice. The 
reduced life expectancy is related to several alterations of the lung e.g. alveolar 
hemorrhage and thickening of the alveolar septa. Btc transgenic mice show also 
significantly reduced pancreas weight compared to their wildtype littermates 
(Schneider, 2005). 
 
1.4. Gt (ROSA)26Sortm/Sor mice 
Mice homozygous for the ROSA26 retroviral insertion display no distinguishing 
phenotype. LacZ is expressed in all tissues of the developing embryo and in most 
tissues of the adults. Crossbreeding with Gt (ROSA)26Sortm/Sor reporter mice 
reveals in which tissue the Cre enzyme is expressed. The transgene consists of a 
floxed neomycin cassette followed by four polyA sequences and the reporter gene 
lacZ (Soriano, 1999). In the presence of the Cre recombinase the floxed sequence 
is deleted and the LacZ sequence can be transcribed.  
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1.5. Breeding strategy 
To obtain Btc transgenic mice in the Egfr knockdown background, pTORU-Btc 
mice were mated with Wa5 mice, resulting in following genotypes: controls 
(Egfr+/+), Wa5 (Egfr+/Wa5), pTORU-Btc (Btc; Egfr+/+) and Btc+Wa5 (Egfr+/Wa5; 
Btc). To obtain Btc transgenic mice in the Erbb4 knockout background, pTORU-
Btc were mated with Erbb4-KO mice, resulting in following genotypes: Controls 
(Erbb4fl/fl , Erbb4fl/+, Erbb4fl/+;Ptf1a-Cre, and Erbb4+/+;Ptf1a-Cre), Erbb4-KO   
(Erbb4fl/fl;Ptf1a-Cre),pTORU-Btc (Btc;Erbb4fl/+,Btc;Erbb4+/+, Btc;Erbb4fl/+;Ptf1a-
Cre, and Btc;Erbb4+/+;Ptf1a-Cre) and Btc+Erbb4-KO (Erbb4fl/fl;Ptf1a-Cre;Btc). 
 
2. Principle of the Polymerase Chain Reaction (PCR) 
With this in vitro method it is possible to multiplicate a selected DNA sequence 
millions of times. The oligonucleotide primers hybridize to two opposite DNA 
strands to flank the sequence of interest. The combination of deoxyribonucleoside 
triphosphates (dNTPs) and a heat-stable DNA polymerase catalyzes the 
elongation of the primers. In each cycle the template is denaturized, and the 
annealed primers are extended by the polymerase. The DNA-polymerase is an 
enzyme that completes single-strand DNA to a double-strand molecule. The 
double-strand DNA is again denaturized in the next cycle and the number of 
templates rises exponentially corresponding to each cycle. Each primer has its 
own annealing temperature, the temperature that allows them to specifically 
hybridize to the DNA strand. 
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2.1. PCR protocol for detecting Btc transgenic mice 
Taq DNA polymerase Kit (Qiagen) containing: 
 
PCR Buffer, 10 x Tris-HCl, KCl, (NH4)SO2, 15mM  MgCl2, pH 8.7 
(20°C) 
Q-Solution   5x concentrated 
MgCl    25mM 
Taq Polymerase 5 U/µl, recombinant 94-kDa DNA polymerase, 
isolated from Thermus aquaticus, cloned in E.coli 
dNTPs Set   100 mM aqueous solutions of dATP, dCTP, dGTP and 
dTTp, each in a separated vial 
 
Reagents for separating the PCR products in agarose gel and visualizing under UV 
light: 
 
Ethidium bromide  0.1% solution in bidistilled H2O 
50x TAE running buffer 242 g TRIS 
    57.1 ml Glacial Acetic Acid 
    100 ml EDTA, 0.5M , pH 8.0 
    Ad 1 l bidistilled H2O 
6x Loading Dye  30% glycerol 
    bromophenol blue 
To confirm that the Btc construct was integrated the following primers were used: 
pTORUseq   5’-CTACAGCTCCTGGGCAACGTG-3’ 
globpA   5’-AGATCTCAGTGGTATTTGTGAGCC 3’ 
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Assay procedure 
We used 100 µl PCR tubes to prepare a 20 µl reaction. The PCR tubes were stored 
on ice during the whole preparation time. 
 
DNA template (about 50 ng)    1 µl 
Sense primer (2 µM)     1 µl 
Antisense primer (2 µM)    1 µl 
dNTPs Mix (1mM)     2 µl 
PCR Buffer, 10x     2 µl 
Q-solution      4 µl 
MgCl2 (25mM)     1.25 µl 
Taq Polymerase (5U/µl)    0.1 µl 
Bidistilled H2O     7.65 µl 
 
For the amplification, a Biometra Uno Thermocycler (Göttingen, Germany) was 
used with the following program: 
1st step: Denaturation    94°C for 4 min 
2nd step:  Denaturation    94°C for 1 min 
3rd step: Annealing    60°C for 1 min 
4th step: Extension    72°C for 2 min 
5th step: Extension    72°C for 10 min 
5th step: Cooling    4°C 
 
Steps 2 to 4 were repeated 35 times before progressing to step 5 and 6 (36 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromide 
and visualized under UV light. 
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2.2. PCR protocol for detecting the mutated Egfr sequence 
Taq DNA polymerase Kit (Qiagen) was used as described above. 
To detect the Wa5 sequence the following primers were used: 
Wa5As1   5’-TAGAGAATGACCCTGACGAG-3’ 
Wa5S6    5’-GCATGTCAAGATCACAGG-3’ 
The product has a total length of 228 bp. 
Assay procedure  
For the amplification the following protocol was used: 
1st step: Denaturation    94°C for 4 min 
2nd step: Denaturation    94°C for 30 sec 
3rd step: Annealing    58°C for 20 sec 
4th step: Extension    72°C for 2 min 
5th step: Extension    72°C for 8 min 
5th step: Cooling    4°C 
 
Steps 2 to 4 were repeated 37 times before progressing to step 5 and 6 (38 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromide 
and visualized under UV light. 
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2.3. PCR protocol for detecting the sequence for the Cre enzyme 
Taq DNA polymerase Kit (Qiagen) was used as described above. 
 
To detect the Cre sequence we used the following primers: 
Cre-1   5’-AATCGCCATCTTCCAGCAGG-3’ 
Cre-2   5’-GATCGCTGCCAGGATATACG-3’ 
Assay procedure 
For the amplification the following protocol was used: 
1st step: Denaturation    94°C for 4 min 
2nd step: Denaturation    94°C for 1 min 
3rd step: Annealing    58°C for 2 min 
4th step: Extension    72°C for 1 min 
5th step: Extension    72°C for 4 min 
5th step: Cooling    4°C 
Steps 2 to 4 were repeated 35 times before progressing to step 5 and 6 (36 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromide 
and visualized under UV light. 
 
2.4. PCR protocol for detecting the floxed Erbb4 sequence 
Taq DNA polymerase Kit (Qiagen) was used as described above 
 
To detect the floxed exon 2 of the Erbb4 gene the following primers were used: 
P20   5’-CAAATGCTCTCTCTGTTCTTTGTGTCTG-3’ 
P22   5’-TTTTGCCAAGTTCTAATTCCATCAGAAGC-3’ 
The product has a total length of 400 bp. 
 
To detect the wildtype allele we used: 
P20   5’-CAAATGCTCTCTCTGTTCTTTGTGTCTG-3’ 
P23   5’-TATTGTGTTCATCTATCATTGCAACCC-3’ 
The product has total length of 350 bp. 
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Assay procedure 
DNA template (about 50 ng)    1 µl 
Sense primer (20 µM)    1 µl 
Antisense primer mutant (20 µM)    1 µl 
Antisense primer wildtype (20 µM)   1 µl 
dNTPs Mix (1mM)     2 µl 
PCR Buffer, 10x     2 µl 
Q-solution      4 µl 
MgCl2 (25mM)     1.25 µl 
Taq Polymerase (5U/µl)    0.1 µl 
Bidistilled H2O     6.65 µl 
 
For the amplification the following protocol was used: 
1st step: Denaturation    94°C for 2 min 
2nd step: Denaturation    94°C for 1 min 
3rd step: Annealing    58°C for 2 min 
4th step: Extension    72°C for 2 min 
5th step: Extension    72°C for 1 min 
5th step: Cooling    4°C 
 
Steps 2 to 4 were repeated 35 times before progressing to step 5 and 6 (36 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromide 
and visualized under UV light. 
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2.5. PCR protocol for detecting the modified LacZ gene driven by the 
cell type-independent ROSA26 promoter 
Taq DNA polymerase Kit (Qiagen) was used as described above. 
 
To detect the modified LacZ gene the following primers were used: 
r26 RGT 1   5’-AAAGTCGCTCTGAGTTGTTAT-3’ 
r26 RGT 2   5’-GCGAAGAGTTTGTCCTCAACC-3’ 
r26 RGT 3   5’-GGAGCGGGAGAAATGGATATG-3’ 
Assay procedure 
DNA template (about 50 ng)    1 µl 
Sense primer      1 µl 
Antisense primer      1 µl 
Antisense primer 2     1 µl 
dNTPs Mix (1mM)     2 µl 
PCR Buffer, 10x     2 µl 
Q-solution      4 µl 
MgCl2 (25mM)     1.25 µl 
Taq Polymerase (5U/µl)    0.1 µl 
Bidistilled H2O     6.65 µl 
 
For the amplification the following protocol was used: 
1st step: Denaturation    94°C for 5 min 
2nd step: Denaturation    94°C for 1 min 
3rd step: Annealing    58°C for 1 min 
4th step: Extension    72°C for 2 min 
5th step: Extension    72°C for 10 min 
5th step: Cooling    4°C 
 
Steps 2 to 4 were repeated 35 times before progressing to step 5 and 6 (36 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromid 
and visualized under UV light. 
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3. Evaluation of gene expression at RNA level 
3.1. Extraction of RNA from tissue 
To isolate RNA from tissue, all working solutions were treated with 0.01% DEPC 
(diethylpyrocarbonat) to inhibit ribonucleases. The treated solutions were left at 
room temperature overnight and autoclaved the other day. In addition, only 
RNase-free pipette tips and gloves were used. After the mice were killed by 
cervical dislocation, the organs were extracted carefully and three samples of 
different regions of the pancreas were immediately put into 100 µl ice-cold 
TRIzol® (Invitrogen, Germany) and homogenized with a tissue homogenizer 
(Miccra, Germany) for 30 sec and stored on ice. Between two samples the 
homogenizer was cleaned with bidistilled water and 0.2 M NaOH. Before the 
RNA isolation samples were left at room temperature for 5 minutes. In the next 
step 200 µl chloroform were added and vortexed to mix the reagents. The samples 
were left for 10 min at room temperature. Then all samples were centrifuged at 
12000x g for 15 min at 4°C. The upper aqueous phase of the supernatant was 
pipetted into a new RNase-free centrifuge tube. 500 µl isopropanol and 50 µl 3M 
sodium acetate were added, mixed by inverting, and the tube was left for 10 
minutes at room temperature. Subsequently the tubes were centrifuged at 12000x 
g for another 10 min at 4°C. The pellets were washed twice with 900 µl 75% 
ethanol, vortexed and centrifuged at 12000x g for 5 minutes at 4°C. The 
supernatant was discarded to dry the pellets for 5 to 10 min. After that the pellet 
was dissolved in 50 µl DEPC treated bidistilled water and left for 10 minutes at 
55°C. We determined the final RNA concentration with the NanoDrop® 
spectrometer ND-1000 (260 nm). The quality of the RNA was confirmed by 
electrophoresis using a 1% agarose gel, stained with ethidium bromide. The 18S 
and 28S RNA bands were visualized under UV light. The isolated RNA was 
stored at -20°C. 
 
3.2. cDNA synthesis 
1 ng RNA was dissolved in DEPC-water to a total volume of 8.5 µl. For the 
transcription the Thermo kit was used according to the manufacture’s 
introduction. Each sample was mixed with 1 µl 10x Reaction buffer and 1 µl 
DNase (1U/µl) and incubated at 37°C for 30 min with shaking. 1 µl EDTA (50 
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mM) was added and incubated at 65°C for 10 min. After this step we added 1 µl 
of Random Hexamer Primers (0.2 µg/ µl) and the mixture was again incubated at 
65°C for 5 min. Then a Master Mix containing following reagents was added to 
each sample: 
 
Master Mix: 
5x Reaction Buffer      4 µl 
dNTPs (10mM)      2 µl 
RiboLockTM RNase Inhibitor (Thermo, Germany)  1 µl 
RevertAidTM Reverse Transcriptase (Thermo, Germany) 1 µl 
 
Incubation protocol: 
 
1st step:    25°C for 10 min 
2nd step:    42°C for 1h 
3rd step:    70°C for 10 min 
 
cDNA was stored at -20°C. 
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3.3. Reverse Transcription PCR (RT-PCR) 
The PCR was performed with the Qiagen® TaqDNA Polymerase Kit. The Kit was 
used according to the manufacture’s introduction. The Master Mix was prepared 
on ice (for each sample): 
During the whole preparation time the PCR tubes were stored on ice. 
cDNA template (about 50 ng/µl)   2 µl 
Sense primer (2 µM)     1 µl 
Antisense primer (2 µM)    1 µl 
dNTPs Mix (1mM)     2 µl 
PCR Buffer, 10x     2 µl 
Q-solution      4 µl 
MgCl2 (25mM)     1.25 µl 
Taq Polymerase (5U/µl)    0.1 µl 
Bidistilled H2O     6.65 µl 
 
For the amplification a Biometra TProfessional Thermocycler (Göttingen, 
Germany) was used with the following protocol: 
1st step: Denaturation  94°C for 5 min 
2nd step: Denaturation  94°C for 1 min 
3rd step: Annealing  60°C (mErbb4), 58°C (Gapdh) for 1min 
4th step: Extension  72°C for 1 min 
5th step: Extension  72°C for 1 min 
5th step: Cooling  4°C 
 
Steps 2 to 4 were repeated 35 times before progressing to step 5 and 6 (36 cycles). 
PCR products were separated in a 1.5 % agarose TAE gel with ethidium bromide 
and visualized under UV light. 
 
Primer: 
mErbb4 sense:  5’-AAATGAAAGCTGGCGACGGG-3’ 
mErbb4 antisense:  3’-CAGAGTCATGTTGGAAGGCC-5’ 
Gapdh sense:   5’-GGTCGGAGTCAACGGATTTG-3’ 
Gapdh antisense:  3’-GTACTGGTGAAGCCGTAGCA-5’ 
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3.4. Microarray analysis 
For microarray analysis mice were bled under ether anesthesia and killed by 
cervical dislocation. Immediately the whole pancreas was infused with RNAlater 
(Sigma, Germany) and stored overnight in 5 ml RNAlater. Microarray analysis 
(G4858A SurePrint G3 Unrestricted GE 8x60K) (Agilent Technologies, 
Germany) was done in cooperation with the Laboratory of Functional Genome 
Analysis at the Gene Center in Munich. 
 
3.5.  Quantitative Real-time RT-PCR  
Pancreas samples were homogenized in TRIzol® (Invitrogen, Germany) as 
described above for RNA isolation. 1 µg of RNA per sample was reverse 
transcribed in a final volume of 40 µl using RevertAid Reverse Transcriptase 
(Thermo, Germany) according to the manufacturer’s instructions. Quantitative 
mRNA expression analysis was performed by real-time quantitative reverse-
transcription polymerase chain reaction (RT-qPCR) using the LightCycler®480 
System and the LightCycler®480 Probes Master (Roche, Germany). The primers 
had a concentration of 0.5 µM. The probe concentration was 0.2 µM. The final 
reaction volume was 10 µl, and cycle conditions were 95°C for 5 min for the first 
cycle, followed by 45 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C for 1 s. 
The quantitative analysis is based on the detection of a signal associated with PCR 
products and the threshold cycle number at which the exponential increase of 
these PCR products could be detected for the first time. Based on these results the 
target gene results were related to the Actb content. Results are listed as fold 
differences in target gene expression relative to Actb transcripts. The ΔCt value of 
the sample was determined by subtracting the average Ct value of the target gene 
from the average Ct value of the Actb gene. Probes were labeled with the reporter 
dye FAM at the 5’ and the quencher dye TAMRA at the 3’ end. For each primer 
pair no-template control and no-RT control assays were performed, which 
produced negligible signals that were usually greater than 40 in Ct value. 
Experiments were performed in duplicates for each sample. Sequences of primers 
(Thermo Fisher Scientific, Germany) are shown in Table 1. 
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Table 1: Sequences of primers used for real-time quantitative PCR and probe 
numbers. 
actin, beta Forward 5’-CGTGAAAAGATGACCCAGATCA-3’ 
 Reverse 5’-CACAGCCTGGATGGCTACGT-3’ 
 Probe #5 
albumin Forward 5’-ATCTGTCTGCAATCCTGAACC-3’ 
 Reverse 5’-ATGCTCACTCACTGGGGTCT-3’ 
 Probe #84 
serine (or cysteine) 
peptidase inhibitor, clade 
A, member 6 
Forward 5’-ACCTTAATCTCCCCAGTGAGC-3’ 
Reverse 5’-CCTGGTGCTTAGGGACAGC-3’ 
Probe #81 
matrix Gla protein Forward 5’-TGTTGCTTGCTCCTTACATGA-3’ 
 Reverse 5’-TACTTTCAACCCGCAGAAGG-3’ 
 Probe #20 
serine (or cysteine) 
peptidase inhibitor, clade 
F, member 1 
Forward 5’-GAGGCAGCTACTCCCCTCA-3’ 
Reverse 5’-CTTCTCTCACAGCCTGCACTC-3’ 
Probe #1 
matrix metallopeptidase 2 Forward 5’-AGACACTGGTCGCAGTGATG-3’ 
Reverse 5’-TGCCATCCTTCTCAAAGTTGT-3’ 
Probe #6 
matrix metallopeptidase 3 Forward 5’-AAGGGTCTTCCGGTCCTG-3’ 
Reverse 5’-ATGCAATGGGTAGGATGAGC-3’ 
Probe #76 
periostin, osteoblast 
specific factor 
Forward 5’-AAGCTCGGCAAGACAAG-3’ 
Reverse 5’-TCAAATCTGCAGCTTCAAGG-3’ 
Probe #73 
gastrin intrinsic factor Forward 5’-AGCTCATGGCCAGTGACAG-3’ 
Reverse 5’-GGAGGACGTGAGAGCCATAA-3’ 
Probe #44 
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cadherin 11 Forward 5’-TATACCACAGCCAGGCGTTT-3’ 
Reverse 5’-CATGGAAAGAGGGATGCAG-3’ 
Probe #50 
collagen, type I, alpha 1 Forward 5’-AGCCCTGGTTCTCGAGGT-3’ 
Reverse 5’-TCTTCGGGTAGCTCTGCTTG-3’ 
Probe #11 
AE binding protein 1 Forward 5’-TTCCCCTACACCAGCCATTA-3’ 
Reverse 5’-CCTGCAGTGGTAGTGGGTAGA-3’ 
Probe #81 
connective tissue growth 
factor 
Forward 5’-CACACCGCACAGAACCAC-3’ 
Reverse 5’-TTCATGATCTCGCCATCG-3’ 
Probe #53 
lumican Forward 5’-CAGCAACATTCCGGATGAG-3’ 
Reverse 5’-TCATTGTGAGATAAACGCAGGT-3’ 
Probe #26 
fibronectin 1 Forward 5’-GACCCGGACATTTTACCAGA-3’ 
Reverse 5’-TATCGGACACCATGCACAAA-3’ 
Probe #14 
preproenkephalin Forward 5’-TACTGGGAACGGGAGACAAC-3’ 
Reverse 5’-TTCGTCATTGTTGGTTGGTGCTCT-3’ 
Probe #83 
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4. Analysis of transgenic and knockout mice 
Mice not used in pancreatitis experiments were also anesthetized with ether and 
blood was collected from the retroorbital sinus, in case the blood was needed for 
subsequent analysis of serum parameters. After that mice were killed by cervical 
dislocation. The abdominal cavity was opened carefully and the organs of interest 
were removed and stored under appropriate conditions for later studies.  
 
4.1. Organ weight analysis 
The removed organs were washed in 1x PBS, blotted dry on a paper towel and 
weighed to the nearest mg. 
 
4.2. Body weight analysis 
One day after birth pups were marked by foot tattooing and weighed for the first 
time. All animals were weighed weekly until the age of 8 or 12 weeks. Only 
littermates, separated by gender were compared. 
 
4.3. Histological analysis 
Organs were fixed for 24 hours in 4% paraformaldehyde (Sigma-Aldrich, 
Germany) solution at 4°C. Fixed tissues were dehydrated through a rising alcohol 
row and embedded in paraffin. 
4% paraformaldehyde solution: 
PBS  
Paraformaldehyd   4 % 
5 M NaOH    0.025%  
 
The solution was heated up to 50°C until the paraformaldehyde powder is 
completely in solution, and then the pH was adjusted to 7,4 by using HCl (Merck, 
Germany). 
III. Animals, Material and Methods     26 
Before staining the sections the embedded tissue was cut with a microtome 
(Thermo, Germany) at a nominal thickness of 3 µm. 
 
4.3.1. Hematoxylin/ eosin (H&E) staining 
Sections were deparaffinized for 20 min in Roti®-Histol (Roth, Germany). Slides 
were rehydrated through a descending alcohol row (5 min, twice in 100 % 
ethanol, 2 min in 90 % ethanol, 2 min in 70 % and 2 min in 50% ethanol) and 
after that the slides were put for a short time in distilled water. The sections were 
stained for five minutes in Mayers Hemalaun (ready-to-use-solution). After that 
the sections were rinsed ten minutes in tap water to stain the nuclei. The slides 
were dipped five minutes into eosin (Sigma, USA), 10 times into 96% EtOH and 
100% isopropanol to be dropped again in Roti®-Histol and finally mounted with 
Pertex (Labonord, Germany). 
 
4.3.2. Immunohistochemical staining 
Two hours before section mice were injected with BrdU (Roche, Germany) (30 
mg/kg body weight) for cell proliferation analysis. The tissues were fixed, 
embedded, and mounted on superfrost glass microscope slides (Menzel Gläser, 
Germany), deparaffinized and rehydrated as described previously. After that the 
sections were treated with 3% H2O2 (Roth, Germany) for 15 minutes and washed 
shortly in distilled water. For antigen retrieval, the sections were boiled for 20 
minutes in a 700 Watt microwave in a 10 mM sodium citrate buffer (pH 6.0). 
Stock citrate acid (0.1 mol): 19.2 g citrate acid in 1 l bidistilled water 
Stock sodium citrate (0.1 mol): 29.4 sodium citrate dihydrate in 1 l bidistilled 
water 
Working solution:  
citric acid (0.1 mol)   27 ml 
sodium citrate (0.1 mol)  123 ml 
Tween® 20    1.5 ml 
bidistilled water up to   1500 ml 
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If the secondary antibody is biotin-conjugated the next step was to incubate them 
first for 15 minutes with an avidin solution (AXXORA GmbH, Germany) wash 
them shortly in TBS and incubate them again for 15 min in a biotin solution 
(AXXORA GmbH, Germany). The biotin solution was only dripped off. After 
that the tissue was covered with the primary antibody solution and incubated 
overnight at 4°C. 
 
Following primary antibodies were used: 
rabbit anti- ERBB4 (1:250 dilution, Santa Cruz, Germany) 
rabbit anti-cleaved caspase-3 (1:200 dilution, Cell Signalling, Germany) 
rat anti-Ki67 (1:200 dilution, Dako, Germany) 
rat anti-BrdU (1:50 dilution, Serotec, Germany) 
 
After the incubation of the primary antibody all slides were washed twice for 5 
min in TBS and covered with the secondary antibody and incubated for 1 hour at 
room temperature (RT): 
goat anti rabbit (1:100 dilution, Vektor BA 1000, USA) 
rabbit anti rat (1:200 dilution, Dako E0468, Germany) 
 
All slides were washed twice in TBS and covered with an avidin-biotin complex 
solution (AXXORA GmbH, Germany) diluted 1/100 for 30 min. 
The slides were washed again in TBS and were finally covered with 3,3‘-
diaminobenzidine (DAB) (KEN-EN-TEC, Denmark) as a chromogen, as long as 
the staining is strong enough. 1% H2O2 (Roth, Germany) was added per ml DAB 
to start the reaction. The staining reaction was stopped by washing the slides in 
bidistilled water. Next, the sections were stained in hematoxylin solution (Mayer, 
Germany) for 30 seconds, rinsed under running tap water for 5 min, dehydrated to 
Roti®-Histol and mounted with Pertex (Labonord, Germany) and cover slides. 
10x TBS: 
 
NaCl       80g 
Tris       30g 
Bidistilled water up to    1l 
Adjusted to pH 7.4 
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4.3.3. X-Gal staining 
Ptf1a-Cre mice were crossbred with Gt (ROSA)26Sortm/Sor mice, which carry a 
modified LacZ gene driven by the cell type-independent ROSA26 promoter. The 
Cre enzyme excises a stop cassette upstream of LacZ and thereby activates the 
expression of ß-galactosidase. The ß-galactosidase marks cells in which Ptf1a is 
expressed and the active ß-galactosidase-expressing locus is inherited by their 
progeny. To detect these cells the histological sections have to be stained with 5-
bromo-4-chloro-3-indolyl-ß-D-galactoside (X-Gal) (Invitrogen, Germany) 
(Kawaguchi, 2002 #68). This enzyme cleaves the disaccharide lactose, releasing 
galactose und glucose. However it is also able to cleave the synthetic substrate X-
Gal, resulting in an indigo color.  
Pancreas and kidney of wildtype and Ptf1a-Cre/Gt (ROSA)26Sortm/Sor-mice were 
incubated for 10 min in the fixative at 4°C and then embedded in Tissue OCT. 8 
µm sections were obtained with a cryostat. 
Fixative: 
6.7 ml  3 % glutaraldehyde  
2.7 ml  37% formaldehyde 
20 µl  NP40 
90.5 ml PBS 
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Staining protocol: 
Sections were air-dried and fixed for 30 min in ice-cold acetone at RT. 
After that the sections were washed in 1 x PBS and stained overnight at 37°C in 
the following staining solution. 
Staining solution: 
46.9 ml  PBS 
100 µl   MgCl2 (1M) 
50 mg  sodiumdeoxycholate 
10 µl NP40 
500 µl K3Fe(CN)6 (500mM) 
500 µl K4Fe(CN)6 x 3 H2O (500mM) 
2 ml X-Gal (50mg/ml) 
 
The next day all slides were washed twice in PBS, stained shortly in eosin, 
dehydrated to Roti®-Histol and mounted with Pertex and cover slides. 
 
4.3.4. Proliferation and apoptosis indices 
For the identification of proliferating and apoptotic cells in the pancreas we used 
BrdU or Ki67 (proliferation) and cleaved caspase-3 (apoptosis) 
immunohistochemical staining of the pancreas. The numerical area density of 
proliferating or apoptotic cells were calculated by dividing the total number of 
immunostained cell nuclei of the exocrine pancreas by the whole number of cell 
nuclei of the exocrine pancreas. Therefore we measured the cross-sectional area of 
the whole pancreas and counted the cell nuclei of one visual field. For these 
measurements a Videoplan Image Processing System (Leica Application Suite 
Software, Germany) coupled to a microscope (Leica, Germany) via a color video 
camera (Leica DFC425, Germany) was used. The measurement was carried out 
with a 25x objective providing an 850x final magnification. The area of the 
exocrine pancreas was measured by tracing its contour with the courser. The 
image analysis system is the able to determine the exact area of the chosen 
surface. 
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5. Protein analysis 
5.1. Sample collection 
Mice were killed by cervical dislocation and tissue samples for protein analysis 
were snapfrozen and stored at - 80°C until needed. 
  
5.2. Extraction of protein from tissue 
Samples stored at -80°C were first weighed and homogenized for 1 minute with a 
tissue homogenizer (Miccra, ART Labortechnik, Germany). The tissues were 
homogenized in protein extraction buffer (for 20 mg of tissue 500 µl extraction 
buffer was used) by 23500 rpm. After each sample the homogenizer was cleaned 
with distilled water and PBS. 
 
5x Laemmli buffer:   1 M Tris (pH 6.8)  65.5 ml 
     Glycerol   100 ml 
     0.5M EDTA (pH 8.0)  2 ml 
     SDS    20 g 
     Bromophenol blue  0.1% 
     Bidistilled water up to 200 ml 
 
Protein extraction buffer:  1M Tris (pH 7.5)  2 ml 
     Tween®   2 ml 
     5x Laemmli buffer  20 ml 
     Bidistilled water  76 ml 
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5.3. Pancreatic cell fractionation 
The fractionation was performed with the QIAGEN Qproteome® Cell 
Compartment Kit according to the manufacturer’s instructions. The used buffers 
(CE1, CE2, and CE3) were treated with 1% protease inhibitor. 49 µl of benzonase 
to 91 µl bidistilled water were added. All solutions were cooled on ice and all 
steps of the fractionation were performed at 4°C. 
Pancreas samples stored at -80°C were put on dry ice until starting the cell 
fractionation. First the tissue was washed in 1 ml ice-cold PBS and split into 
pieces of 20 to 26 mg. These pieces were homogenized for 5 s in a tissue 
homogenizer in 500 µl CE1 buffer. The suspension was transferred into Qiagen 
shredder homogenizer tubes and centrifuged at the lowest power for 2 min. The 
pellet was carefully resuspended in the supernatant of the collection tube using a 
pipette. The content was transferred into a new centrifuge tube and filled with 500 
µl ice-cold CE1 buffer. In the next step the centrifuge tubes were rotated in an 
overhead shaker for 10 min and subsequently centrifuged at 4000x g for another 
10 min. The supernatant (fraction 1) containing cytoplasmic proteins was pipetted 
into a fresh centrifuge tube and stored on ice. 1 ml CE2 buffer was used for 
resuspending the pellet. The resuspended sample was rotated using an overhead 
shaker for 30 sec, after that centrifuged at 6000x g for 10 min to receive the 
fraction 2 in the supernatant. The fraction 2 consists of membrane proteins. The 
pellet was again resuspended with 20 µl of benzonase solution by snapping 
against the centrifuge tube and left at room temperature for 15 min. Finally, 500 
µl of CE3 buffer were added, the pellet was resuspended by pipetting and the 
sample was mixed in an overhead shaker for 10 min at 4°C. To finish this step it 
was centrifuged by 6800 x g for 10 min at 4°C. The supernatant contains the 
nuclear proteins (fraction 3). For later protein concentration determination the 
samples have to be dissolved in protein extraction buffer. Therefore the samples 
were mixed with a 4-fold proportion of ice-cold acetone and incubated at RT for 
15 min. The samples were centrifuged at 12000x g for 10 min at 4°C. After the 
supernatant was carefully discarded, the pellet was dried in a vacuum centrifuge 
for 10 min. Fraction 1 and 2 were resuspended in 180 µl, fraction 3 in 120 µl 
protein extraction buffer. 
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5.4. Determination of the protein concentration 
To determine the protein concentration of the samples a bicinchoninic acid (BCA) 
assay was performed. We used a stock solution (4 mg/ml) of bovine serum 
albumin (Roth, Germany) and serial dilutions to create a standard curve. 50 µl of 
the standard and the samples of unknown concentration (1:10 dilution in PBS) 
were pipetted in a 96-well plate. 200 µl of a mixture of BCA and 4 % CuSO4 
(Sigma-Aldrich, Germany) were added to each well. After that the plate was 
incubated at 37°C for 30 min to measure the absorbance at 562 nm. The standard 
curve was created by plotting the absorbance of the standards versus their known 
protein concentrations and used to calculate the unknown concentrations of the 
protein samples. 
 
5.5. SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
20 µg of protein of each sample were pipetted into centrifuge tubes and filled up 
with 1xLaemmli buffer to attain the same volume. In some experiments it was 
necessary to add 5% of 2-mercaptoethanol (Merck, Germany) to the samples. All 
samples were incubated at 95°C for 5 min and after that stored on ice. Protein 
separation was performed using the Mini Protean® 3 cell system (Bio Rad, 
Germany). To prepare the separating gel a 50 ml glass beaker was used. Under 
continuous agitation the different substances were added and poured into the 
space between the glass plates of the system, leaving enough space for the 
stacking gel (about 2.5 cm). The polymerization process lasts 1 hour. To ensure an 
even surface the separating gel it was covered with bidistilled water. After 
complete polymerization the water was discarded and the stacking gel was 
prepared and poured on top of the separating gel and a comb was inserted. After 
complete polymerization of the stacking gel (30 min), the plates were connected 
to the electrophoresis chambers, filled with SDS-PAGE electrophoresis buffer and 
the comb was removed. A molecular weight standard (MBI Fermentas, 
PageRulerTM Prestained Protein Ladder #SM0671, Germany) was pipetted into 
the first well. Samples were then loaded and the electrophoresis was performed 
initially at 100V for 10 min and then at 140V until the bromophenol blue front left 
the separating gel. 
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separating gel: bidistilled water  3.35 ml 
   1.5 M Tris   2.5 ml 
   30% acrylamide  4.0 ml 
   10% SDS   100 µl 
   10% ammoniumpersulfate 50 µl 
   Temed    5 µl 
 
stacking gel:  bidistilled water  7.0 ml 
   1.5 M Tris   1.25 ml 
   30% acrylamide  1.5 ml 
   10% SDS   100 µl 
   10% ammoniumpersulfate 100 µl 
   Temed    5 µl 
 
SDS-PAGE electrophoresis buffer:  Tris   30.3 g 
      Glycine  144 g 
      SDS   10 g 
      bidistilled water up to   1 l 
 
5.6. Electrophoretic blotting 
A semidry electro blotting apparatus (Bio-Rad, Germany) was used to transfer the 
separated proteins to a PVDF membrane (Millipore). The gel blotting paper (Bio-
Rad, Germany) in the same size of the gel was soaked in 1x transfer buffer and 
placed on the bottom of the electrode. The blotting paper was covered with the 
membrane and the gel exactly in the same position. On top we placed again a 
sheet of blotting paper soaked with transfer buffer. To eliminate air bubbles we 
used an empty test tube to squeeze carefully the whole construct. The upper 
electrode was put on the blotting apparatus and connected to a power supply (Bio-
Rad). The blotting procedure took place 1 hour at 15 mA. After the transfer the 
membranes were immediately lettered with a pen, not solvable in methanol and 
stained in Ponceau S (Sigma, Germany). The membranes were carefully dried and 
stored at 4°C. 
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10x transfer buffer:    Tris   58.2 g 
     Glycine  29.2 g 
     SDS   3.7 g 
     bidistilled water up to   1 l 
 
5.7. Detection of the antigen 
To activate the membranes with the transferred proteins, they were rinsed 1 min in 
methanol and then washed 3 times for 5 min in TBS-T buffer at RT in a 
hybridization oven (Bachofer, Germany). The next step was to incubate the 
membranes in blocking solution for one hour again at RT in a hybridization oven 
without heating. The blocking solution, either instant skimmed milk (Roth, 
Germany) or BSA (Roth, Germany), was matched to the solution in which the 
secondary antibody was diluted. After that the primary antibody was diluted in 
2.5% milk or 5% BSA in TBS-T. If the primary antibody was not diluted in the 
same solution as in the step before, the membranes were washed 4 times for 5 min 
in TBS-T. The incubation of the primary antibody took place overnight and at 
4°C. At the next day all membranes were rinsed 3 times in TBS-T before the 1 
hour lasting incubation with the secondary antibody could be started. Before the 
detection process the membranes were washed 3 times for 5 min in TBS-T. 
Detection was performed by incubating the membranes 1 min with 2 ml of ECL 
detection reagent (GE Healthcare, Germany) the membrane was covered with 
plastic and exposed to an ECL film (GE Healthcare, Germany). 
 
10x TBS buffer:  Tris   30 g 
   NaCl   80 g 
   Bidistilled water up to 1 l 
 
TBS-T buffer:  1x TBS 
0.1 % Tween 20 
 
blocking solution: 2.5 or 5% instant skimmed milk powder or BSA in TBS-T 
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Primary antibodies: 
Goat anti-SerpinA6 (1:1000 dilution in 2.5% BSA, AF: 4065 (R&D, Germany)) 
Rabbit anti-SerpinF1 (1:1000 dilution in 2.5% BSA, QC0455 (Sigma-Aldrich, 
Germany)) 
Rabbit anti-44/42 MAPK (1:2000 dilution in 5% BSA, 9102 (Cell Signalling, 
Germany)) 
Rabbit anti-phospho 44/42 MAPK (1:2000 dilution in 5% BSA, 4370 (Cell 
Signalling, Germany)) 
Rabbit anti-Akt (1:1000 dilution in 5% BSA, 4691 (Cell Signalling, Germany)) 
Rabbit anti-phospho-Akt (1:2000 dilution in 5% BSA, 4060 (Cell Signalling, 
Germany)) 
Rabbit anti-Erbb2 (1:1000 dilution in 2.5% milk powder, 284 (Santa Cruz, 
Germany)) 
Rabbit anti-HistoneH3 (1:1000 dilution in 5% BSA, 9717 (Cell Signalling, 
Germany)) 
Mouse anti-Erbb4(C-7) (1:1000 dilution in 2.5% milk powder, 8050 (Santa Cruz, 
Germany)) 
Rabbit anti-GAPDH (1:5000 dilution in 5% BSA, 2118 (Cell Signalling, 
Germany)) 
 
Secondary antibodies: 
Donkey anti-goat (1:1000 dilution in 5%BSA, HAF: 109 (R&D, Germany)) 
Donkey anti-rabbit (1:2500 dilution in 5% milk powder, NA: 934V (GE 
Healthcare, Germany)) 
Rabbit anti-mouse (1:2500 dilution in 5% milk powder, 7076 (Cell Signalling, 
Germany))  
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6. Acute pancreatitis 
6.1. Caerulein-induced pancreatitis model 
All mice were placed for 18 h on a special grid for fasting, water was offered ad 
libitum. Two different protocols were used. A 3 hour lasting pancreatitis was 
induced by two intraperitoneal (i.p.) injections of caerulein (Sigma, USA) (50 µg 
caerulein/kg mouse, dissolved in 0.9% NaCl) and the animals were killed 3 hours 
after the first injection. A 24 hour lasting pancreatitis was induced by 8 injections 
of caerulein and the mice were killed 24 hours after the first injection. After the 
last caerulein injection the fasting-grid was removed and food was offered ad 
libitum. Before the mice were killed by cervical dislocation they were 
anesthetized in ether and blood was collected for serum analysis from the 
retroorbital sinus. The mice were dissected carefully and the whole pancreas was 
extracted. First three small samples of different parts of the pancreas were 
collected and immediately frozen on dry ice for protein analysis. Again three 
samples, but smaller than those for protein analysis, were taken out of three 
different parts of the pancreas and homogenized in RLT buffer (Qiagen, 
Germany) with 1% 2-mercaptoethanol and frozen in liquid nitrogen. For 
histological analysis the remaining part of the pancreas was fixed for 24 h in 4 % 
PFA at 4°C and embedded in paraffin. 
 
6.2. L-arginine pancreatitis model 
To make sure that the results of the caerulein-induced pancreatitis are 
reproducible in other pancreatitis models we also performed the L-arginine 
pancreatitis model. For the L-arginine model of pancreatitis non-fasted mice were 
used. Pancreatitis was induced by i.p. application of 4 g/kg arginine per body 
weight (Sigma, Germany). A sterile solution of L-arginine hydrochloride (8%) 
was prepared in 0.9% NaCl (B.Braun, Germany). The pH of this solution was 
adjusted to 7.0. Mice received 2 injections of L-arginine (4 g/kg). Blood was 
collected under ether anaesthesia at 0, 24, 48, and 72 hours after the first injection 
from the retroorbital sinus. After that the mice were sacrificed and tissue samples 
were removed and further processed. 
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6.3. Pain treatment with metamizole 
Because pancreatitis is a very painful disease we treated all mice used in 
pancreatitis experiments with 70 mg/kg metamizole (Vetalgin®) (Intervet, 
Germany). Metamizole does not influence the caerulein-induced inflammation 
(Stumpf, unpublished). The metamizole applications were given orally before the 
first caerulein injection and 4, 8, 12 and 20 hours after starting the experiment 
(Fig.3.1). 
 
 
Figure 3.1: Metamizole treatment of mice used in pancreatitis experiments. 
 
6.4. Serum analysis 
Blood collected from the retroorbital sinus was allowed to clot for 1h at 4°C and 
then centrifuged for 10 min at 1700x g. The serum was separated from the 
remaining components of the blood and was pipetted in a separate centrifuge tube 
and was stored at -80°C. For measuring the serum parameters amylase and lipase 
the serum samples were diluted 1:10 with 0.9% NaCl (B.Braun, Germany) and 
stored on dry ice until needed for the measurement. The measurement was 
performed by the institute “Klinische Chemie” of the “Klinikum Rechts der Isar”, 
Munich. 
 
6.5. Histological scoring 
To evaluate the three major parameters of AP (necrosis, inflammation and 
edema), a special histological score was generated. To perform this score H&E-
stained histological pancreatic sections of 3 µm were prepared. The pancreas was 
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cut in longitudinal sections five times in a distance of 25 µm. The sections were 
stained in H&E and graded in a blinded manner. To evaluate the severity of the 
edema, the necrosis and the inflammatory cell infiltration in 20 visual fields of 
each surface of the slides were examined and estimated. The 50x magnification 
was used for the edema and the 400x (HPF) for the inflammation and the necrosis. 
The histological score was performed as described below: 
 
Edema:  
0 = absent 
0.5 = focal expansion of interlobar septae 
1 = diffuse expansion of interlobar septae 
1.5 = same as 1 + focal expansion of interlobular septae 
2 = same as 1 + diffuse expansion of interlobular septae 
2.5 = same as 2 + focal expansion of interacinar septae 
3 = same as 2 + diffuse expansion of interacinar septae 
3.5 = same as 3 + focal expansion of intercellular septae 
4 = same as 3 + diffuse expansion of intercellular septae 
 
Acinar necrosis:  
0 = absent 
0.5 = focal occurrence of 1-4 necrotic cells/HPF 
1 = diffuse occurrence of 1-4 necrotic cells/HPF 
1.5 = same as 1 + focal occurrence of 5-10 necrotic cells/HPF 
2 = diffuse occurrence of 5-10 necrotic cells/HPF 
2.5 = same as 2 + focal occurrence of 11-16 necrotic cells/HPF 
3 = diffuse occurrence of 11-16 necrotic cells/HPF 
3.5 = same as 3 + focal occurrence of >16 necrotic cells/HPF 
4 = diffuse occurrence of >16 necrotic cells/HPF 
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Inflammation:  
0 = 0-1 intralobular leukocytes/HPF 
0.5 = 2-5 intralobular leukocytes/HPF 
1 = 6-10 intralobular leukocytes/HPF 
1.5 = 11-15 intralobular leukocytes/HPF 
2 = 16-20 intralobular leukocytes/HPF 
2.5 = 21-25 intralobular leukocytes/HPF 
3 = 26-30 intralobular leukocytes/HPF 
3.5 = 30-35 intralobular leukocytes/HPF 
4 = >35 intralobular leukocytes/HPF 
 
7.  Statistical analysis 
The statistical analysis was performed with a two-tailed student’s t-test except for 
the results of the qRT-PCR study. The qRT-PCR data were analyzed with a two-
tailed Mann-Whitney U-test. All Data are presented as means ± SD or mean ± 
SEM (histological scoring) and graphs were generated with Prism 4.0. 
Quantitative RT-PCR values were related to the mean value of the control group 
and data are presented as box plots with medians. All results were analyzed for 
significance (Graph Pad Prism 4.0 for Windows, Graph Pad Software, and USA). 
Differences were considered statistically significant if P < 0.05. 
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8. Material 
8.1. Equipment 
 
Accu-jet® pro pipette controller  Brand, Wertheim, Germany 
Agarose gel electrophoresis chamber MWG-Biotech, Ebersberg, Germany 
Agarose gel electrophoresis power   Bio Rad, Munich, Germany 
Blunt forceps     Aesculap, Tuttlingen, Germany 
Bulldog forceps    Aesculap, Tuttlingen, Germany 
Centrifuges 5417, 5417R   Eppendorf, Hamburg, Germany 
Chyo JL-200 (analytical balance)  Chyo, Japan 
Chyo MJ-3000 (analytical balance)  Chyo, Japan 
Color video camera (DFC425)  Leica, Wetzlar, Germany 
Curix60 Tabletop processor   Agfa HealthCare, Greenville, USA 
Duran®-Schott glass ware   DURAN Group, Wertheim, Germany 
Electrophoresis chamber   MWG-Biotech, Ebersberg, Germany 
ELISA reader Spectra Max 250  Molecular Devices, Sunyvale, USA 
EPS 500/400 Electrophoresis  
Power Supply     Pharmacia Fine Chemicals, NJ, USA 
Fine scissors     Aesculap, Tuttlingen, Germany 
Gel documentation system   Intas, Göttingen, Germany 
GeneAmp PCR System 9700 Applied Bisosystems, Foster City, 
USA 
Glass case for glass rack   Roth, Karlsruhe, Germany 
Glucometer     Abott, Ludwigshafen, Germany 
Heating plate with magnetic stirrer  IKA process equipment, Staufen, 
Germany 
Homogenizer Miccra  ART Labortechnik, Müllheim, 
 Germany 
Hybridization oven    Bachofer, Reutlingen, Germany 
Laboratory scale, BP221S   Sartorius, Göttingen, Germany 
Laboratory scale, BP4100S   Sartorius, Göttingen, Germany 
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Laminar flow cabinet  BDK, Sonnenbühl-Genkingen, 
 Germany 
LightCycler 480    Roche, Mannheim, Germany 
MicroPlate reader    Tecan, Männedorf, Swizzerland 
Microtome     Microm, Walldorf, Germany 
Microscope     Leica, Wetzlar, Germany 
Microwave     Siemens, Munich, Germany 
Mini Protean® 3 Cell    Bio Rad, Munich, Germany 
MS1 Minishaker  IKA process equipment, Staufen, 
Germany 
NanoDrop-1000 spectrophotometer  NanoDrop Technologies, Wilmington 
USA 
PCR-machine/thermal cycler   Biometra, Göttingen, Germany 
PIPETMAN® P (1000µl)   Gilson, Limburg, Germany 
PIPETMAN® P (100µl)   Gilson, Limburg, Germany 
PIPETMAN® P (10µl)   Gilson, Limburg, Germany 
PIPETMAN® P (200µl)   Gilson, Limburg, Germany 
PIPETMAN® P (20µl)    Gilson, Limburg, Germany 
PIPETMAN® P (2µl)   Gilson, Limburg, Germany 
Pointed scissors    Aesculap, Tuttlingen, Germany 
Power Pac 300    Bio Rad, Munich, Germany 
Power Supply PPS200-1D   MWG-Biotech, Ebersberg, Germany 
Rotating shaker    Infors AG, Bottmingen, Germany 
Semidry electroblotting apparatus  Bio-Rad, Munich, Germany 
Spectrophotometer    Beckman, Palo Alto, USA 
Table centrifuge (5417R)   Eppendorf, Hamburg, Germany 
Thermomixer 5436    Eppendorf, Hamburg, Germany 
Thermocycler TProfessional   Biometra, Göttingen, Germany 
Ultraschall Sonorex Super RK 102 H Bandelin, Berlin, Germany 
UV-Crosslinker    Biometra, Göttingen, Germany 
VakuLab s3000 (Autoclave)   MMM group, München, Germany 
Watch maker forceps    Aesculap, Tuttlingen, Germany 
Water bath SUB14  Grant Instruments, Royston, Great 
Britain 
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8.2. Consumables 
 
96-well cell culture plates (flat-based) BD, Heidelberg, Germany 
96-well real-time PCR plates   Eppendorf, Hamburg, Germany 
Blotting paper     Bio-Rad, Munich, Germany 
Centrifugation tube (15 ml, 50 ml)  Becton Dickinson, Heidelberg, 
 Germany 
Centrifuge tube (0.5 ml, 1.5 ml, 2.0 ml) Eppendorf, Hamburg, Germany 
Chemoilluminiscence film   GE Healthcare, Munich, Germany 
Cover glass slides  VWR International, Darmstadt, 
 Germany 
Cryotube 1.0 ml    Nunc A/S, Roskilde, Denmark 
Filter paper     GE Healthcare, Munich, Germany 
Glass microscope slides  Menzel-Gläser, Braunschweig, 
 Germany 
Heat sealing foil    Eppendorf, Hamburg, Germany 
Heparinized capillary tubes   Brand, Gießen, Germany 
Histology cassettes    Medite, Burgdorf, Germany 
Microarrays       Agilent Technologies, Germany 
PCR-reaction-tubes    G. Kisker GbR, Steinfurt, Germany 
Petri dishes (diameter 10 cm)  Becton Dickinson, Heidelberg, 
 Germany 
Plastic tubes (5 ml)  Greiner Bio-One, Frickenhausen, 
 Germany 
PVDF membrane    Millipore, Billerica, USA 
Real-time PCR plates (96 well)  Eppendorf, Hamburg, Germany 
Rundbodenröhrchen, 5 ml   Falcon/BD, Heidelberg, Germany 
Standard rodent chow   Ssniff, Soest, Germany 
Sterican® cannulas (18G, 20G)  B.Braun, Melsungen, Germany 
Superfrost slides    Menzel, Braunschweig, Germany 
Syringes (2, 5, 10, 20 ml)  Codan Medical ApS, Roedby, 
 Denmark 
Uni-Link embedding cassettes  Engelbrecht, Edermüde, Germany 
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8.3. Chemicals 
 
0.9% NaCl solution    B.Braun, Melsungen, Germany 
2-mercaptoethanol    Merck, Darmstadt, Germany 
ABC (Avidin-biotin complexes)  Vector Laboratories, Burlingame, 
 USA 
Acetone     CLN, Niederhummel, Germany 
Acrylamide, 30%    Bio-Rad, Munich, Germany 
Agarose     Invitrogen, Karlsruhe, Germany 
Amersham ECL WB Detection Reagent GE Healthcare, Munich, Germany 
Ammonium persulfate, 10%   Bio-Rad, Munich, Germany 
Bichinonic acid  Sigma-Aldrich, Deisenhofen, 
 Germany 
BrdU      Roche, Mannheim, Germany 
Bromphenol blue    Serva, Heidelberg, Germany 
BSA      Roth, Karlsruhe, Germany 
Caerulein     Sigma, St. Louis, USA 
Chloroform     Merck, Darmstadt, Germany 
Collagenase II     Biochrom, Berlin, Germany 
CuSO4  Sigma-Aldrich, Deisenhofen,  
 Germany 
DEPC  Sigma-Aldrich, Deisenhofen, 
Germany 
DNA Rehydration Solution   Promega, Mannheim, Germany 
DNase I Amp Grade, 1U/µl   Invitrogen, Karlsruhe, Germany 
DNase I reaction buffer, 10x   Invitrogen, Karlsruhe, Germany 
DNase I, Amplification Grade  Invitrogen, Karlsruhe, Germany 
dNTPs (dATP, dTTP, dCTP, dGTP) MBI Fermentas, St. Leon-Rot, 
 Germany 
DTT, 0.1 M     Invitrogen, Karlsruhe, Germany 
ECL solution (#34076; #34077)  Thermo Scientific, Rockford, USA 
EDTA      VWR International, Darmstadt, 
Germany 
EDTA solution, 25 mM   Invitrogen, Karlsruhe, Germany 
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Enzyme mix     Roche, Mannheim, Germany 
Eosin Y     Sigma, St.Louis, USA 
Ethanol     Merck, Darmstadt, Germany 
Ethanol 99% with 2-Butanon 1%  HEMA GmbH, Nürnberg, Germany 
Ethidiumbromide    Roth, Karlsruhe, Germany 
Glacial acetic acid    Roth, Karlsruhe, Germany 
Glycine     Merck, Darmstadt, Germany 
Glycerine     Roth, Karlsruhe, Germany 
Glucose solution    B.Braun, Melsungen, Germany 
HCl      Merck, Darmstadt, Germany 
H2O2      Roth, Karlsruhe, Germany 
Hematoxylin solution according to Mayer Sigma-Aldrich, Deisenhofen, 
Germany 
Hot-start Taq, 5 U/µl    Quiagen, Hilden, Germany 
Instant skimmed milk powder  Roth, Karlsruhe, Germany 
Isopropanol p.a.    Merck, Darmstadt, Germany 
Isopropanol, technisch   Roth, Karlsruhe, Germany 
KCl      Roth, Karlsruhe, Germany 
KH2PO4      Merck, Darmstadt, Germany 
L-arginine hydrochloride   Sigma, Deisenhofen, Germany  
Loading dye (6x)    MBI Fermentas, St. Leon-Rot, 
Germany 
Methanol     Merck, Darmstadt, Germany 
MgCl2, 25 mM     Invitrogen, Karlsruhe, Germany 
MgCl2, 25 mM    Qiagen, Hilden, Germany 
Molecular weight marker   MBI Fermentas, St. Leon-Rot, 
Germany 
Na2HPO4     Merck, Darmstadt, Germany 
NaCl      Roth, Karlsruhe, Germany 
NaOH      Roth, Karlsruhe, Germany 
Nuclei Lysis Solution    Promega, Mannheim, Germany 
PageRulerTMPrestained Protein Ladder MBI Fermentas, St. Leon-Rot, 
Germany 
Paraformaldehyde    Sigma-Aldrich, Deisenhofen, 
Germany 
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Path Tissue Oct    LABONORD S.A.S, Gutenberg, 
Germany 
PCR buffer with MgCl2, 10x   Roche, Mannheim, Germany 
PCR buffer, 10x    Qiagen, Hilden, Germany 
Pertex (mounting medium)   Medite, Burgdorf, Germany 
Ponceau S Solution    Sigma, Deisenhofen, Germany 
Protein Precipitation Solution  Promega, Mannheim, Germany 
Proteinase K     Roche, Mannheim, Germany 
pUC mix molecular weight marker  MBI Fermentas, St. Leon-Rot, 
Germany 
Q-Solution     Qiagen, Hilden, Germany 
Rabbit serum     PromoCell, Heidelberg, Germany 
Random hexamer primer   Invitrogen, Karlsruhe, Germany 
RLT buffer     Qiagen, Hilden, Germany 
RNAlater®     Sigma, Deisenhofen, Germany 
Rnase      Roche, Mannheim, Germany 
RNeasy Mini kit    Qiagen, Hilden, Germany 
Roti®-Histol     Roth, Karlsruhe, Germany 
RT buffer, 10x    Invitrogen, Karlsruhe, Germany 
SDS      Serva, Heidelberg, Germany 
Sigma Fast DAB Tablet Set   Sigma-Aldrich, Taufkirchen, 
Germany 
Sodium citrate    Merck, Darmstadt, Germany 
Skimmed milk powder   Roth, Karlsruhe, Germany 
Taq DNA polymeras Kit   Quiagen, Hilden, Germany 
Taq Polymerase, 5 U/µl   Quiagen, Hilden, Germany 
Temed      Bio-Rad, Munich, Germany 
Tris      Roth, Karlsruhe, Germany 
TRizol® reagent    Invitrogen, Karlsruhe, Germany 
Tween®20     Sigma-Aldrich, Deisenhofen, 
Germany 
Vectastain Elite ABC Kit   AXXORA GmbH, Lörrach, Germany 
Washing buffer    Roche, Mannheim, Germany 
X-gal       Invitrogen, Karlsruhe, Germany 
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8.4. Drugs  
 
0.9% NaCl solution    B.Braun, Melsungen, Germany 
Diethyl ether     Carl Roth GmbH, Karlsruhe, 
Germany 
Histoacryl® liquid skin glue   B.Braun, Melsungen, Germany 
Metamizole-Sodium (Vetalgin®)  Intervet, Unterschleißheim, Germany 
 
8.5. Software 
 
Agilent Microarray  Agilent Technologies, Inc., Santa 
 Clara, USA 
GraphPad 4.0 software   GraphPad, LaJolla, USA 
Microsoft Office 2007   Microsoft, Redmond, USA 
Videoplan Image Processing System Leica Application Suite Software, 
      Weztlar, Germany 
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IV. RESULTS 
1. Is the protective effect of BTC during AP mediated by the 
EGFR?  
1.1. Generation of Btc transgenic mice in an Egfr-deficient background 
(Btc+Wa5) 
To obtain Egfr+/Wa5 (Wa5) mice with additional ubiquitous BTC-overexpression 
we crossbred Wa5 mice with pTORU-Btc mice (L2). These double transgenic 
mice show a severe impairment in the function of the EGFR (dead kinase 
receptor) and ubiquitous BTC-overexpression. 
 
1.2. Investigation of Btc+Wa5 mice during caerulein-induced 
pancreatitis  
To investigate if the protective effect of BTC in AP is EGFR-dependent, the 
caerulein pancreatitis model was used to evaluate the consequences of the loss of 
EGFR function in mice with ubiquitous BTC-overexpression. A 24-hour-lasting 
pancreatitis was induced by 8 injections of caerulein and the mice were killed 24 
hours after the first injection. The 3-month-old male mice were fasted for 18 hours 
before starting the experiment. The serum markers of pancreatitis, serum amylase 
and lipase, were measured for all genotypes (Btc, Wa5, Btc+Wa5 and WT) (Fig. 
4.1). The chemical analysis of serum after the 24-h-lasting pancreatitis showed 
significantly reduced values of amylase and lipase in Btc transgenic mice and 
Btc+Wa5 mice compared to wildtype and Wa5 mice. 
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Figure 4.1: Serum amylase (A) and lipase (B) levels of the four animal groups 
(Btc, Wa5, Btc+Wa5 and WT) after a 24-h-lasting pancreatitis (male, aged 3 
months), (n=6/group), *: P<0.05, **: P<0.01. 
A histological scoring was employed to evaluate the number of necrotic and 
inflammation cells and the grade of edema to estimate the grade of induced AP. 
50 visual fields per animal and H&E-stained pancreas were evaluated. BTC-
overexpressing mice as well as Btc+Wa5 were protected, indicating that the 
protective effect of BTC is EGFR-independent (Fig. 4.2 and Fig. 4.3). 
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Figure 4.2: Histological scoring shows that the protective effect of BTC is not 
influenced by the loss of EGFR. Evaluation of the necrotic cells (A) the 
inflammation cells (B) and the edema (C) in the four animal groups (Btc, Wa5, 
Btc+Wa5 and WT) after a 24-hour-lasting pancreatitis (n=6/group), *: P<0.05, **: 
P<0.01. 
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Figure 4.3: Examples of H&E-stained histological sections employed for the 
scoring of necrosis, inflammation and edema. Wildtype (A) and Wa5 mice (C) 
show the main indications of AP with invasion of inflammation cells, necrosis and 
edema. Btc transgenic mice (B) and Btc+Wa5 mice (D) are protected, (male, aged 
3 months). Scale bar represents 100 µm. 
 
1.3. Determination of the apoptosis rate after a 3-h-lasting caerulein-
induced pancreatitis in Btc+Wa5 mice 
Previous studies revealed that apoptosis may be a main reason for the protective 
effect of BTC in AP. To determine the apoptosis rate we used 11-week-old male 
animals subjected to a 3-hour-lasting caerulein-induced pancreatitis. The 3-hour-
lasting pancreatitis was induced by two injections of caerulein and the animals 
were killed 3 hours after the first injection. The number of positive cells was 
significantly increased in both Btc and Btc+Wa5 mice (Fig. 4.4). 
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Figure 4.4: Cell apoptosis in the exocrine pancreas after pancreatitis (3h). The 
apoptosis rate (number of activated caspase-3-positive cells in %) is significantly 
increased in exocrine cells of the pancreas of Btc and Btc+Wa5 mice (n=4 
males/group; age: 11 weeks), *: P<0.05. 
 
2. Investigation of the role of ERBB4 in the development of 
the exocrine pancreas  
2.1. Generation of conditional Erbb4 knockout (Erbb4-KO) mice 
To analyze the role of ERRB4 in the exocrine pancreas development and the AP, 
we generated animals carrying a homozygously floxed exon 2 within the Erbb4 
gene (Erbb4flox/flox) and expressing in addition hemizygously Cre recombinase 
under the control of the Pft1a promoter (Erbb4fl/fl/Ptf1a/ tm1(cre)Hnak). 
 
2.1.1. Expression study 
2.1.1.1. Validation of Erbb4 deletion in the exocrine pancreas of the Erbb4-
KO mouse by RT-PCR 
RNA was isolated from several organs of control mice, expressing the murine 
wild type Erbb4 sequence (Erbb4), and Erbb4-KO mice (male, aged 8 weeks) 
with the Erbb4 sequence after conditional knockout under the control of Ptf1a 
promoter (Erbb4-KO). The RNA was reversely transcribed into cDNA which can 
be amplified by RT-PCR and separated by agarose gel electrophoresis. Erbb4 
expression could be confirmed in the heart, the kidney and the pancreas. A lower 
expression could be shown in the lung and no expression was found in the spleen 
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of wildtype mice. Due to a possible minimal Ptf1a activity in heart, lung, and 
kidney, these organs of Erbb4-KO mice showed also a minimal expression of the 
deleted Erbb4 gene. The less intense band in the pancreas sample can be 
explained by the fast degradation of the pancreatic RNA due to autodigestion 
(Fig. 4.5). 
 
 
 
 
 
 
 
 
Figure 4.5: Expression pattern of murine wild type Erbb4 (Erbb4) and Erbb4 after 
conditional knockout under the control of the Ptf1a promoter (Erbb4-KO). Erbb4 
expression (531 bp) in heart, kidney and pancreas, lower expression in lung, no 
expression in spleen of wildtype mice (A). Erbb4 and Erbb4-KO (lacking exon 2, 
length: 379 bp) expression in Erbb4-KO mice in heart, kidney and to a lower 
extend in the lung. The pancreas shows only expression of Erbb4 lacking exon 2 
(Erbb4-KO) (B). Bidistilled H2O was used as negative control and Gapdh 
expression as standard. 
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2.1.1.2. Visualization of Cre by X-gal staining 
To verify the activity of Cre in the exocrine pancreas, we crossbred Ptf1a-Cre 
mice with the reporter mouse line Gt(ROSA)26Sortm/Sor. Gt(ROSA)26Sortm/Sor mice 
show an inducible ubiquitous expression of modified LacZ . Based on this LacZ 
expression, ß-galactosidase is expressed in cells with Cre activity, since Cre 
excises a stop cassette upstream of LacZ. ß-galactosidase activity can be 
visualized by X-gal staining. Cre was only expressed in the pancreas of Ptf1a-Cre 
mice, but not in other tissues. Fig. 4.6 shows an X-gal staining in the pancreas and 
in the kidney as an example. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Examples of X-gal-stained pancreas (A, B) and kidney (C, D) of 8-
week-old control (A, C) and Ptf1a-Cre +ROSA-lacZ mice (B, D) showing the 
specifity of the Cre enzyme in the exocrine pancreas. Scale bar represents 50 µm. 
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2.1.1.3. Detection of ERBB4 by immunohistochemical staining 
The immunohistochemical staining demonstrated the expression of the ERBB4 
receptor in the exocrine pancreatic tissue of the control but not in the exocrine 
pancreas of the Erbb4-KO mouse (Fig. 4.7). 
 
 
 
 
 
 
 
Figure 4.7: Immunoreactivity of ERBB4 in the exocrine pancreas of an 8-week-
old male control (A) and Erbb4-KO mouse (B). The Erbb4-KO mouse shows 
almost no immunoreactivity for ERBB4. Scale bar represents 50 µm. 
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2.1.2. Body and organ weight analysis of Erbb4-KO mice 
The body weights of Erbb4-KO mice and their wildtype littermates of both 
genders were recorded until the age of 12 weeks (Fig. 4.8). The loss of the 
ERBB4 receptor in the exocrine pancreas did not influence the body weight gain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Postnatal growth curves of Erbb4-KO (KO) mice and their wildtype 
(WT) littermates (n =7) until the age of 12 weeks. 
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2.1.3. Exocrine pancreas 
2.1.3.1. Evaluation of the pancreas weight of Erbb4-KO mice 
The absolute pancreas weight and the pancreas weight in relation to the body 
weight were analyzed in 3-month-old and 1-year-old Erbb4-KO mice and their 
wildtype littermates, without revealing any effects based on the loss of ERBB4 
(Fig. 4.9, Fig. 4.10). 
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Figure 4.9: Absolute pancreas weights of male, 3-months-old (A) and 1-year-old 
female (B) Erbb4-KO mice and controls (n=4). 
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Figure 4.10: Relative pancreas weights of male, 3-months-old (A) and 1-year-old 
female (B) Erbb4-KO mice and controls (n=4). 
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2.1.3.2. Histology of the exocrine pancreas of Erbb4-KO mice 
The pancreas of 3-month-old male Erbb4-KO knockout mice showed no obvious 
change in weight, size and constitution. Also in H&E-stained histological sections 
the pancreas did not show any structural changes (Fig. 4.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Examples of H&E-stained sections of the pancreas of 3-month-old 
male Erbb4-KO (A, B) and wildtype mice (C, D) in different magnifications. 
Scale bar represents 100 µm (A, C) and 50 µm (B, D). 
 
3. Investigation of Erbb4-KO mice in caerulein-induced 
pancreatitis  
3.1. Caerulein-induced pancreatitis 
To analyze if the loss of the ERBB4 receptor influences AP, we applied the 
caerulein-induced pancreatitis model to wildtype and Erbb4-KO mice. For 
inducing the 24-hour-lasting pancreatitis we employed 5-month-old males. AP 
was induced by 8 injections of caerulein and the mice were killed 24 hours after 
the first injection. The mice were fasted for 18 hours before starting the 
experiment. The first serum markers of pancreatitis, serum amylase and lipase, 
A B 
D C 
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were measured in the two groups. No significant differences between wildtype 
and Erbb4-KO mice could be detected (Fig. 4.12). 
 
 
 
 
 
 
 
 
Figure 4.12: Serum amylase (A) and lipase (B) levels of 5-month-old male 
wildtype (WT) and Erbb4-KO (ERBB4KO) mice after a 24-hour-lasting, induced 
pancreatitis, (n=6/group). 
 
The histological scoring was employed in the same way as described in chapter 
1.2 to evaluate the severity of AP. 50 visual fields of H&E-stained pancreas per 
animal were examined without revealing any differences between wildtype and 
Erbb4-KO mice (Fig. 4.13 and Fig. 4.14). 
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Figure 4.13: Histological scoring of caerulein-induced pancreatitis (24h) in 5-
months-old male wildtype (WT) and Erbb4-KO mice (ERBB4-KO) evaluating the 
necrotic cells (A) the inflammation cells (B) and the edema (C), (n=6/group). 
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Figure 4.14: Examples of H&E-stained histological sections employed for the 
scoring of necrosis, inflammation and edema. Wildtype (A) and Erbb4-KO mice 
(B) show similar severity of AP. Scale bar represents 100 µm. 
 
After the 24-hour-lasting pancreatitis the absolute and relative pancreas weight 
was measured. No differences between the two groups could be observed (Fig. 
4.15). 
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Figure 4.15: Absolute (A) and relative (B) pancreas weight of 5-month-old male 
Erbb4-KO compared to their wildtype (WT) littermates, after a 24-h-lasting 
induced pancreatitis (n=5/group). 
 
3.2. Caerulein-induced pancreatitis followed by a regeneration period of 
7 days 
As the ERBB4 receptor seems to play a role in tissue regeneration in other organs, 
we induced a 24-hour-lasting pancreatitis with caerulein in male Erbb4-KO and 
wildtype mice. After the pancreatitis experiment the animals had a regeneration 
period of 7 days before they were sacrificed. Serum amylase and lipase were 
measured (Fig. 4.16) and the pancreas weight was documented without revealing 
B A 
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a significant difference between wildtype and knockout mice (Fig.4.17). The 
number of apoptotic cells and the proliferation rate were also assessed by using an 
apoptosis and proliferation index (Fig. 4.18). Again, no significant difference 
between the two animal groups could be detected. 
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Figure 4.16: Serum amylase (A) and lipase (B) levels of 7-month-old male 
wildtype (WT) and Erbb4-KO mice after a 24-hour-lasting induced pancreatitis 
followed by a 7-day-lasting regeneration period (n=5/group).  
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Figure 4.17: Absolute (A) and relative (B) pancreas weight of 7-month-old male 
wildtype (WT) and Erbb4-KO mice after the regeneration period of 7 days 
(n=5/group). 
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Figure 4.18: Apoptosis index (number of activated caspase-3-positive cells in % 
(A) and proliferation index (number of Ki67-positive cell nuclei in %) (B) of 7-
month-old wildtype (WT) and Erbb4-KO mice after the induced pancreatitis (24h) 
and the subsequent regeneration period of 7 days, (n=4/group). 
 
4. Investigations on the involvement of ERBB4 in mediating 
BTC effects in the exocrine pancreas 
4.1. Generation of Btc transgenic mice in the Erbb4 knockout 
background (Btc+Erbb4-KO) 
To obtain mice with loss of ERBB4 in the exocrine pancreas and ubiquitous BTC-
overexpression, we crossbred Erbb4-KO mice with Btc transgenic mice. 
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4.2. Body weight analysis of Btc+Erbb4-KO mice 
In previous studies it has already been shown that Btc transgenic mice show 
reduced body weight gain. Wildtype littermates showed the same body weight as 
Erbb4-KO mice and Btc transgenic mice as Btc+Erbb4-KO (Fig. 4.19).   
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Figure 4.19: Postnatal growth curves of male (A) and female (B) Btc+Erbb4-KO 
(ERBB4KO+BTC) mice until the age of 9 weeks. As control groups we used 
wildtype (WT), Btc (BTC) and Erbb4-KO (ERBB4KO) littermates, (n=8/group). 
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4.3. Exocrine Pancreas 
4.3.1. Evaluation of the pancreas weight of Btc+Erbb4-KO mice  
It is already known that the pancreas weight of BTC-overexpressing mice is 
significantly reduced compared to wildtype littermates and that this effect is 
EGFR-independent. In previous studies we found out that the loss of ERBB4 does 
not influence the pancreas weight (chapter 2.1.3.1). We compared the pancreas 
weight of male wildtype, Erbb4-KO, Btc transgenic and Btc+Erbb4-KO mice. 
The reduced pancreas weight in mice overexpressing BTC is not mediated by 
ERBB4 because Btc+Erbb4-KO mice continue to show reduced pancreas weight 
(Fig. 4.20). 
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Figure 4.20: Absolute (A) and relative (B) pancreas weight of male wildtype 
(WT), Erbb4-KO (KO), Btc transgenic (BTC) and Btc+Erbb4-KO 
(BTC+ERBB4KO) mice, (n=4, 3 months), ***: P<0.001. 
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4.3.2. Histology of the pancreas  
The pancreas of the four genotype groups (wildtype, Erbb4-KO, Btc and 
Btc+Erbb4-KO) at the age of 1 year was employed for histological analysis to 
assess whether the loss of ERRB4 influences the effect of BTC on the 
development of the exocrine pancreas. The absence of ERBB4 seems to activate a 
structural change of the acinar and duct cells of Btc transgenic mice (Fig. 4.21). 
These altered areas resemble lesions known as pancreatic intraepithelial neoplasia 
(PanIN) and show a higher number of BrdU-positive, proliferating cells (Fig. 
4.22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21: Examples of H&E-stained sections of the pancreas of 1-year-old Btc 
transgenic (A), Btc+Erbb4-KO (B), Erbb4-KO (C) and wildtype mice (D). Scale 
bar represents 50 µm. 
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BrdU-stained histological sections revealed that in the altered areas of the 
pancreatic tissue of Btc+Erbb4-KO mice a higher number of proliferating, BrdU 
positive nuclei could be detected (Fig. 4.22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: BrdU immunohistochemical labelling of 1-year-old wildtype (A), 
Erbb4-KO (B), Btc (C) and Btc+Erbb4-KO (D) mice. Scale bar represents 100 
µm. 
 
4.3.3. Acute pancreatitis 
4.3.3.1. Caerulein-induced pancreatitis 
A 24-hour-lasting pancreatitis was induced by 8 injections of caerulein and the 
female mice, aged 4 months, were killed 24 hours after the first injection. The 
mice were fasted for 18 hours before starting the experiment. The first serum 
markers of pancreatitis, serum amylase and lipase were measured in the four 
groups (Fig. 4.23). The analysis of serum after the 24-hour-lasting pancreatitis 
revealed that the Btc+Erbb4-KO mice showed similar values of amylase and 
lipase compared to Erbb4-KO and wildtype mice. Only Btc transgenic mice 
showed significantly reduced serum levels of amylase and lipase. Thus, the 
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protective effect of BTC is absent without the ERBB4 receptor and therefore 
mediated by ERBB4. 
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Figure 4.23: Serum amylase (A) and lipase (B) levels of the four animal groups 
(Btc, Erbb4-KO, Btc+Erbb4-KO and wt), (aged 4 months, female) after a 24-
hour-lasting, induced pancreatitis (n=4/group), *: P<0.05. **: P<0.01. 
 
The histological scoring was employed as in the chapters above (1.2) to evaluate 
the number of necrotic and inflammation cells and the grade of edema to estimate 
the severity of the induced pancreatitis. The Btc transgenic animals represented 
the only group with significantly decreased values in all categories compared to 
all other genotypes where the pancreatitis was manifested with its typical features. 
Thus, without the ERBB4 receptor, the protective effect of BTC is no longer 
present (Fig. 4.24 and Fig. 4.25). 
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Figure 4.24: Histological scoring of the caerulein-induced pancreatitis (24h) 
evaluating necrotic cells (A) inflammation cells (B) and edema (C). Btc+Erbb4-
KO mice compared with the respective animal groups (n=5/group), (females, aged 
4 months) *: P<0.05, **: P<0.01, ***: P<0.001. 
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Fig.  
 
 
 
 
 
 
 
 
Figure 4.25: Examples of H&E-stained histological sections employed for the 
scoring of necrosis, inflammation and edema. Wildtype (A), Btc+Erbb4-KO mice 
(D) and Erbb4-KO mice (C) show the main indications of AP with invasion of 
inflammation cells, necrosis and edema (3 months-old females). Only the Btc 
transgenic mice (B) are protected. Scale bar represents 100 µm. 
 
4.3.3.2. Pancreatitis model induced by L-arginine 
To ensure that the results of the caerulein-induced pancreatitis can be reproduced 
in other pancreatitis experiments, we applied the L-arginine pancreatitis model to 
male Btc+Erbb4-KO mice. The mice received food ad libitum. The L-arginine 
pancreatitis was induced by 2 hourly injections of L-arginine (4 g/kg). Blood was 
collected 0, 24, 48, and 72 hours after the first injection. After that, the mice were 
sacrificed and tissue samples were removed. Serum amylase was measured in the 
four groups. The chemical analysis of serum after 0, 24, 48 and 72 hours revealed 
that the Erbb4-KO mice with additional BTC-overexpression showed similar 
values of amylase and lipase as Erbb4-KO and wildtype mice (Fig 4.26). Thus, 
the pancreatitis induced by L-arginine showed results similar to those in the 
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pancreatitis model induced by caerulein.  
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Figure 4.26: Serum amylase levels of the four groups (Btc, Erbb4-KO, 
Btc+Erbb4-KO and wt), after a 24-hour-lasting, induced pancreatitis (aged 6 
months, males). After 24 hours, 48 hours and after 72 hours only the Btc 
transgenic mice are protected and show significantly decreased amylase levels in 
the serum (n=4/group), *: P<0.05, **: P<0.01 
 
The histological scoring was performed as in the caerulein-induced pancreatitis 
model. The Btc transgenic showed significantly decreased values in all categories 
compared to wildtype, Erbb4-KO and Btc+Erbb4-KO animals, in which the 
pancreatitis was manifested with its typical features. Thus, the loss of the ERBB4 
receptor in the exocrine pancreas leads to the loss of protection by BTC (Fig. 4.27 
and Fig. 4.28). 
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Figure 4.27: Histological scoring of 6-month-old male Btc+Erbb4-KO mice 
(BTC+ERBB4KO) and the respective control groups (WT, ERBB4KO and BTC) 
evaluating the necrotic cells (A) the inflammation cells (B) and the edema (C), 
(n=4/group), *: P<0.05, **: P<0.01, ***: P<0.001. 
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Figure 4.28: Examples of H&E-stained histological sections employed for the 
scoring of necrosis, inflammation and edema. Wildtype (A), Btc+Erbb4-KO mice 
(D) and Erbb4-KO mice (C), (aged 6 months, male) show the main indications of 
AP with immigration of inflammation cells, necrosis and edema. Only the Btc 
transgenic mice (B) are protected. Scale bar represents 100 µm. 
 
 
 
 
 
 
 
 
 
 
 
B A 
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5. Pathways activated by BTC signalling mediating the 
protection against AP 
The only signalling cascade mediated by BTC that is known to be relevant for the 
protective effect in AP is the stress activated protein kinase (SAPK) pathway. The 
main pathways activated by the ERBB receptors are the MAPK (mitogen 
activated protein kinase) and AKT/PKB (3-kinase activated protein kinase B) 
pathways. It is also known that the cytoplasmatic tail of the ERBB4 receptor can 
be shaded by a γ-secretase and translocate to the nucleus where it can act as 
transcription factor.  
 
5.1. SAPK signalling 
To confirm an increased activation of the SAPK by BTC, a Western blot analysis 
was performed for phosphorylated SAPK and total SAPK (Fig. 4.29). Samples 
from male wildtype, Btc transgenic mice, Btc+Erbb4-KO and Erbb4-KO mice 
subjected to caerulein-induced 3-h-lasting pancreatitis were investigated by 
Western blot analysis. Phosphorylated SAPK is increased in the pancreas of BTC 
transgenic mice but not in the pancreas of BTC transgenic mice with additional 
deletion of ERBB4. These results suggest an activation of the SAPK pathway via 
BTC with an involvement of ERBB4. 
     
 
 
 
 
 
 
Figure 4.29: Western blot analysis of SAPK and pSAPK in pancreatic tissue of 
Btc transgenic (BTC), wildtype (WT), Btc+Erbb4-KO (ERBB4-KO+BTC) and 
Erbb4-KO (ERBB4-KO) mice, (male, 3 months) with acute 3-hour-lasting 
pancreatitis. α–tubulin (TUBA1A) was used as loading control. 
WT BTC BTC+ERBB4KO ERBB4KO 
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5.2. MAPK signalling 
To detect the activation of MAPK by BTC a Western blot analysis was performed 
for phosphorylated MAPK and total MAPK (Fig. 4.30). Caerulein-induced 3-h-
lasting pancreatitis activated MAPK signalling, as demonstrated by the increased 
phosphorylation of MAPK. There was no difference in total MAPK detection or 
in the detection of its phosphorylated form in BTC-overexpressing mice compared 
to the wildtype mice in both groups (with and without 3-h-lasting pancreatitis). 
Thus, AP induces MAPK signalling, whereas BTC-overexpression has no effect 
on MAPK signalling. 
 
Figure 4.30: Western blot analysis of MAPK signalling in pancreatic tissue of 
male Btc transgenic (TG) and wild type mice (WT) with acute 3-hour-lasting 
pancreatitis (1-6) compared to healthy littermates (7-12), (male, 3 months). 
GAPDH was used as loading control. 
 
5.3. AKT signalling 
AKT/PKB is frequently involved in apoptotic pathways. We detected total AKT 
and the phosphorylated form of AKT in Western blot analysis. Western blot 
analysis revealed no alterations in AKT signalling in both animal groups (male, 3 
months), indicating that BTC does not activate the AKT pathway in AP (Fig. 
4.31). 
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Figure 4.31: Western blot analysis of AKT signalling in pancreatic tissue of Btc 
transgenic (BTC tg) and wild type (wt) mice with and without 3-hour-lasting 
pancreatitis induced by caerulein (male, 3 months). GAPDH was used as loading 
control. 
 
5.4. Nuclear localization of ERBB4 in pancreatic tissue 
We performed a protein fractionation of pancreatic tissue to confirm the migration 
of ERBB4 and its intracellular domain (ICD) into the nucleus. Pancreatic tissue of 
wildtype and Btc transgenic animals was fractionated in its subcellular 
components (membrane, cytoplasm and nucleus). 
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5.4.1. Control of fractionation of pancreatic tissue 
To confirm the success of the fractionation, Western blot analysis using antibodies 
detecting specific subcellular components were carried out: GAPDH for the 
cytoplasmatic fraction, ERBB2 for the membrane fraction, and Histone H3 for the 
nuclear fraction (Fig. 4.32).  
 
 
 
 
 
 
Figure 4.32: Western blot analysis as control of pancreatic tissue fractionation. 
The indicated proteins can be detected exclusively in their appropriate cell 
compartment. Cytoplasmatic fraction (1-4), membranous fraction (5-8), nuclear 
fraction (9-12), the first two lanes are wild type (WT), the last two lanes Btc 
transgene (TG) samples. 
 
5.4.2. Subcellular ERBB4 detection in pancreatic tissue 
To localize the ERBB4 receptor and its intracellular domain (ICD), the fractions 
were separated by SDS-PAGE and blotted onto a PVDF membrane. Pancreas 
samples of 3-month-old, male Btc transgenic animals and wild type littermates 
were used. 
Even in control mice the ERBB4 receptor was not exclusively found in the 
membrane as expected, but also in the cytoplasmic fraction and in the nucleus. 
Whereas the level of ERBB4 remained constant in the membrane of BTC-
overexpressing mice a significant increase of ERBB4 could be observed in 
cytoplasmic and nuclear fractions (Fig. 4.33, A). 
The 120 kDa ICD of the ERBB4 receptor was not detectable in the membranous 
fraction of the pancreatic tissue, neither in the wild type, nor in the transgenic 
samples. In wildtype mice the soluble ICD could be distinctly detected in the 
GAPDH 
ERBB2 
Histone H3 
membrane nucleus cytoplasm 
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cytoplasm even in control mice. However, the amount of ICD increased in the 
cytoplasm in the pancreas sample of BTC-overexpressing mice compared to the 
wildtype mice or to the control (wildtype heart). In wildtype samples no ICD 
could be detected in the nucleus. However, small amounts of ICD could be 
detected in the nucleus of tissue samples of BTC-overexpressing mice, indicating 
a successful translocation of the soluble ICD to the nucleus upon BTC binding 
(Fig. 4.33, B).  
 
Figure 4.33: Western blot analysis and detection of ERBB4 (A) and its ICD 
(intracellular domain) (B) in subcellular compartments after fractionation of 
pancreatic tissue of wildtype (WT, 1-3) and Btc transgenic (TG, 4-6) mice (male, 
aged 3months). As positive control the subcellular compartments of heart tissue of 
wildtype mice was used (7). 
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5.5. Upregulated genes in Btc transgenic mice with and without AP 
5.5.1. Microarray analysis 
To find out which genes, activated by BTC via ERBB4 could be important for the 
protection against AP by BTC, pancreas samples of 9-week-old male Btc 
transgenic mice and controls, with and without AP (3h) were evaluated by 
microarray analysis. Table 3 shows the genes significantly upregulated in 
transgenic animals with 0h- and 3h-pancreatitis compared with 0h- and 3h-
pancreatitis control littermates. Genes only regulated in transgenic animals with 
3h-pancreatitis compared with control animals with 3h-pancreatitis are shown in 
Table 4. 
 
Table 3: Genes significantly (P<0.05) upregulated in pancreas samples of Btc 
transgenic animals (male, aged 9 weeks) at time points of 0h- and 3h-pancreatitis, 
(n=5/group). Yellow marked genes were subsequently measured by qRT-PCR. 
 
PROBE SET ID FC 
(LOG2) 
P-VALUE ID-NUMBER  GENNAME 
A_55_P2178036 
A_51_P133562 
A_66_P118635 
A_51_P160713 
A_51_P426270 
A_55_P2050902 
A_55_P2017939 
 
6.08 
5.92 
3.24 
5.01 
2.38 
3.67 
1.84 
 
0.00001 
0.00001 
0.00023 
0.00023 
0.00031 
0.00031 
0.00034 
 
NM_007618 
NM_007618 
ENSMUST00000095451 
NM_009654 
NM_008597 
NM_021564 
NM_011836 
 
Serine peptidase inhibitor, clade A, member 6 
Serine peptidase inhibitor, clade A, member 6 
Gm46  
Albumin 
Matrix Gla protein 
Fetuin beta 
Laminin gamma 3 
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Table 4: Genes significantly (P<0.05) upregulated in pancreas samples of Btc 
transgenic mice (male, aged 9 weeks) in 3h-pancreatitis only, (n=5/group). 
Yellow marked genes were subsequently measured by qRT-PCR. 
PROBE SET ID FC 
(LOG2) 
P-
VALUE 
ID-NUMBER GENNAME 
A_55_P1967548 
A_55_P1973159 
A_55_P2207255 
A_55_P2035946 
A_51_P341736 
A_55_P1954086 
A_52_P14456 
A_51_P167527 
A_51_P157042 
A_51_P255699 
A_51_P283473 
A_55_P2149951 
A_55_P1968488 
A_52_P437795 
A_55_P2064328 
A_51_P182303 
A_55_P2020577 
A_55_P1952618 
A_55_P2130178 
A_55_P2035662 
A_55_P2142028 
A_55_P2118520 
A_55_P2128853 
A_51_P146633 
 
2.38 
1.86 
1.44 
2.00 
1.92 
3.01 
1.95 
2.48 
1.13 
1.53 
1.64 
1.42 
2.39 
1.81 
1.56 
1.89 
1.68 
1.39 
1.72 
1.38 
1.42 
2.47 
1.37 
0.99 
 
0.00001 
0.00100 
0.00288 
0.00288 
0.00288 
0.00650 
0.00650 
0.00857 
0.01031 
0.01031 
0.01031 
0.01591 
0.02395 
0.02611 
0.02611 
0.02611 
0.02716 
0.03182 
0.03182 
0.03182 
0.03391 
0.04088 
0.04125 
0.04369 
 
ENSMUST0000010611 
NM_011340 
NM_016911 
NM_001002927 
NM_008610 
NM_001198766 
NM_026886 
NM_008524 
NM_010217 
NM_010809 
NM_026271 
NM_019412 
NM_008118 
NM_009866 
NM_008481 
NM_007743 
NM_008788 
NM_007895 
NM_010233 
NM_009636 
NM_030179 
NM_007742 
NM_001012766 
ENSMUST00000143791 
 
GM6370 
Serine peptidase inhibitor, clade F, member 1 
Sushi-repeat-containing protein 
Preproenkephalin 
Matrix metallopeptidase 2 
Periostin, osteoblast specific factor 
Serine/arginine repetitive matrix 4 
Lumican 
Connective tissue growth factor 
Matrix metallopeptidase 3 
Fin bud initiation factor homolog (zebrafish) 
Periaxin 
Gastric intrinsic factor 
Cadherin 11 
Laminin, alpha 2 
Collagen, type I, alpha 2 
Procollagen C-endopeptidase enhancer protein 
Eosinophil-associated,ribonuclease A family,member 2 
Fibronectin 1 
AE binding protein 1 
CAP-GLY domain containing linker protein family    
Collagen, type I, alpha 1 
Eosinophil-associated,ribonuclease A family,member 12 
bicaudal C homolog 1 
 
 
Based on a literature research Cbg (Serpina6), Pedf (Serpinf1), Penk and with less 
probability Mmp2 and Mmp3, could play a role in AP and might be responsible 
for the protective effect of BTC. 
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5.5.2. qRT-PCR study of Cbg, Pedf, Mmp2 and 3 and Penk 
To confirm the results of the microarray study, a quantitative real-time PCR was 
employed. cDNA samples of 9-week-old, male Btc transgenic and control mice 
with AP (3h) were used. All investigated genes were significantly increased in Btc 
transgenic mice at RNA level (Fig.4.34) 
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Figure 4.34: Quantitative RT-PCR analysis of the expression of Cbg, Pedf, Mmp2 
and Mmp3 and Penk in pancreatic tissue of Btc transgenic mice (Tg) and controls 
(Co) with a 3-h-lasting pancreatitis, (n=5/group), (male, aged 9 weeks), *: P<0.05, 
**: P<0.01, ***: P<0.001. 
 
5.6. CBG and PEDF protein expression analysis 
CBG and PEDF were investigated in Western blot analysis using pancreas 
samples of wildtype and Btc transgenic mice (male, 8 weeks) with and without AP 
(3h) (Fig. 4.35). The Western blot analysis validated the upregulation of CBG in 
Btc transgenic mice. The protein could be detected in the pancreas of BTC-
overexpressing mice to a higher level than in the controls. The results of the 
Western blot analysis confirmed the involvement of CBG in BTC signalling. The 
Western blot analysis of PEDF confirmed its upregulation in AP in both animal 
groups. However, there is no difference between Btc transgenic mice and the 
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control group. This data suggest that PEDF might play a role in AP, but not in 
BTC signalling.  
 
                  
 
Figure 4.35: Western blot analysis of CBG and PEDF in pancreatic tissue of Btc 
transgenic (Tg) and wildtype (Co) mice (male, 8 weeks) with acute 3-hour-lasting 
pancreatitis (AP) compared to healthy littermates. GAPDH was used as loading 
control. 
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V. DISCUSSION 
1. BTC-induced protection against AP requires normal 
EGFR activity 
Previous studies describing the dominant expression of ERBB4 in the exocrine 
pancreas, and the fact that the reduced pancreas weight of Btc transgenic mice is 
not mediated by the EGFR, suggested that the protective effect of BTC against AP 
is ERBB4 dependent (Dahlhoff, 2010). Our results from the pancreatitis 
experiment employing mice without functional EGF receptor and additional 
ubiquitous BTC-overexpression validated this assumption since these animals 
were further on protected against AP. Nevertheless, as the Wa5 mouse shows a 
residual activity of the EGF receptor (Lee, 2004) it cannot be fully excluded that 
the protection could be mediated by this residual receptor activity.  
 
2. Loss of pancreatic ERBB4 does not affect mouse 
development and growth 
To find out more about the role of pancreatic ERBB4, and in special whether the 
loss of ERBB4 in the pancreas can affect mouse development and growth, we 
investigated conditional Erbb4-KO mice, which are deficient for ERBB4 in the 
exocrine pancreas. The pubs were viable and showed no conspicuities compared 
to their wildtype littermates. Because mice with ubiquitous ERBB4 deletion die 
between day 10 and 11 after fertilization (Gassmann, 1995), it was not predictable 
if the loss of ERBB4 in the exocrine pancreas would be compatible with normal 
development and the birth of viable pubs. As no differences regarding the body 
weight gain compared to wildtype littermates could be detected, our data indicate 
that ERBB4 expression in the exocrine pancreas is not important for normal 
mouse development. 
ERBB receptors are known to play an important role in cell differentiation and 
development (Massague, 1993), (Holbro, 2003). Surprisingly, the loss of ERBB4 
has no influence on normal pancreatic development. The pancreas of Erbb4-KO 
mice showed no macroscopic alterations and even in H&E stained histological 
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sections we could not observe any changes in cell structure or general 
constitution. 
In case of additional BTC-overexpression, the implications of ERBB4 loss seem 
to be more complex. In Erbb4-KO mice with additional BTC-overexpression the 
body weight is only influenced by the overexpressed BTC as established in 
previous studies (Schneider, 2005). The body weight analysis revealed that Btc 
transgenic mice as well as the Erbb4-KO mice with additional BTC-
overexpression showed a significantly reduced body weight gain compared to 
wildtype littermates and Erbb4-KO mice. That implies that Erbb4-KO mice 
behave like wildtype mice and Erbb4-KO mice with additional BTC 
overexpression like Btc transgenic mice, demonstrating that the pancreatic 
ERBB4 receptor does not mediate the reduced body weight in Btc transgenic 
mice. One explanation for an impaired body weight gain of Btc+Erbb4-KO mice 
could result from morphologic changes in the exocrine pancreatic tissue, affecting 
the ability to store and synthesize the necessary amount of digestive enzymes.  
The pancreas weight of Erbb4-KO mice with additional BTC-overexpression and 
in Btc transgenic mice is significantly reduced compared to wildtype mice and 
Erbb4-KO mice. According to these results, the ERBB4 receptor is not 
responsible for the reduced pancreas weight caused by overexpressed BTC. This 
implies that another ERBB receptor or a combination of different receptors has to 
be responsible for this effect.  
Interestingly, in H&E and BrdU stained histological pancreatic sections of 1-year-
old Erbb4-KO mice with additional BTC-overexpression, structural changes in the 
acinus and duct cells, resembling lesions known as pancreatic intraepithelial 
neoplasia (PanIN) were apparent. As a further evidence for a neoplastic alteration 
these areas showed a higher number of BrdU positive, proliferating cells. 
Considering the complexity of the ERBB system with its different pathways, it 
seems possible that the overexpressed BTC is able to bind and activate different 
hetero- or homodimers of the ERBB receptor family even without its binding 
partner ERBB4. The ERBB2/3 heterodimer is known to be involved in 
carcinogenesis (Pinkas-Kramarski, 1998) and could therefore be responsible for 
these alterations in the pancreatic tissue. Notably, BTC is able to activate several 
heterodimers of ERBB receptors, including the ERBB2/3 heterodimer (Alimandi, 
1997), (Pinkas-Kramarski, 1998). 
V. Discussion      82 
3. Role of ERBB4 in AP with or without BTC-
overexpression 
Even if the loss of pancreatic ERBB4 does not affect pancreatic development, it is 
possible that Erbb4-KO mice show an altered course of AP. ERBB4 is known to 
play a role in inflammation processes such as lung inflammation (Purevdorj, 
2008) and Crohn’s colitis (Frey, 2009) by mediating proaptotic pathways (Sartor, 
2001), (Vidal, 2005). This activation of proapoptotic pathways might lead to a 
higher apoptosis rate and thus protection against AP. However, these findings 
could not be validated in our AP experiments where Erbb4-KO mice behaved like 
wildtype mice. Consequently, the loss of ERBB4 itself does not affect the course 
and severity of AP. 
We also found out that the loss of ERBB4 does not influence the capability of the 
pancreatic tissue to regenerate after induced AP. Erbb4-KO mice suffering from 
induced 24-h-lasting pancreatitis, followed by a regeneration period of 7 days, did 
not show any evidences of reduced cell regeneration. In this case, ERBB4 does 
not seem to mediate pathways responsible for cell regeneration and survival, as 
suggested in previous studies (Frey, 2009). 
However, Btc transgenic mice with additional loss of pancreatic ERBB4 are no 
longer protected against AP. Importantly, both cearulein and L-arginine 
pancreatitis models were used to exclude a caerulein-dependent effect. This 
finding ultimately confirms our presumption that ERBB4 mediates the protective 
effect of BTC.  
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4. Possible mechanisms mediating BTC-ERBB4 protection 
against AP 
To learn more about the mechanisms underlying the ERBB4-mediated protection 
against AP, several signalling pathways such as SAPK, MAPK and AKT were 
investigated. ERBB receptors can also be processed from the cell surface by the 
action of secretases, definitely another interesting aspect as this relocalization 
might reveal an alternative signalling pathway (Linggi, 2006). On this way, 
ERBB4 may have the ability to influence the expression of several genes itself by 
acting as transcription factor (Kainulainen, 2000). 
In previous studies, the protection of BTC could be demonstrated to be associated 
with an increased phosphorylation of SAPK (Dahlhoff, 2010). According to our 
Western blot analysis, phosphorylated SAPK is increased in the pancreas of Btc 
transgenic mice but not in the pancreas of Btc transgenic mice with additional 
deletion of ERBB4. These results suggest an activation of the SAPK pathway by 
BTC with an involvement of ERBB4. However, other main pathways of the 
ERBB receptors like MAPK or AKT could be involved in AP. Analysis of MAPK 
and AKT revealed no activation of these pathways by BTC. The MAPK pathway 
is activated in AP, probably due to its proinflammatory properties (Clemons, 
2002), but obviously BTC is not involved in this signalling cascade. No 
alterations were found in AKT signalling, what differs to the findings in previous 
studies, where phosphorylated AKT is decreased during AP (Yang, 2011). This is 
a rather controversial result considering the established antiapoptotic properties of 
AKT (Li, 2015).  
Because neither MAPK nor AKT signalling pathways are involved in the 
protection against AP by BTC, the endocytotic pathway of ERBB4 became even 
more interesting. It has already been reported that upon receptor activation the 
intracellular domain (ICD) of ERBB4 can be released in the cytoplasm and on this 
way might act as a transcription factor (Omerovic, 2004), (Lee, 2002), (Sundvall, 
2008). The detection of ERBB4 in the different cell compartments revealed, as 
expected, a robust expression of ERBB4 in the membrane. Physiologically, the 
full length receptor may also be present in the cytoplasm and in the nucleus as a 
result of receptor internalization and degradation. In Btc transgenic mice, the 
detection of ERBB4 is increased in the nucleus. It cannot be excluded that even 
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the non-activated receptor could affect different intracellular processes and 
thereby influence the course of AP. 
After activation of membrane bound ERBB4, a γ-secretase is able to cleave a 120 
kDa ICD from the receptor, which can translocate to the nucleus. The increase of 
ICD in the cytoplasm and in the nucleus of Btc transgenic mice could be caused 
by the activation of ERBB4 by the overexpressed BTC, thus BTC could directly 
regulate the ICD amount in the cytoplasm. It can be assumed that the ICD acts as 
a transcriptional regulator as it has already been reported in several other tissues 
(Omerovic, 2004), (Lee, 2002), (Sundvall, 2008) and therefore might regulate the 
expression of different genes. In a further study it would be interesting to 
investigate the role of ICD in AP in more detail.  
Against the background that ERBB4 may have the ability to influence gene 
expression indirectly and directly, we wanted to detect ERBB4 target genes which 
are relevant to the protection against AP. We investigated pancreas samples of Btc 
transgenic and wildtype mice with and without caerulein-induced AP in 
microarray analysis. The results of the microarray analysis revealed several genes 
which were upregulated by BTC signalling, including Cbg and Pedf. In previous 
studies, Cbg has been directly involved in the protection against AP (Muller, 
2007). Other members of the Serpin-family, for instance Spi2A, have also been 
described to be involved in the protection against AP (Neuhofer, 2013) or such as 
Pedf in the development of pancreatic adenocarcinoma (Grippo, 2012). 
Upregulation of Cbg and Pedf in the pancreas of Btc transgenic mice suffering 
from AP was confirmed by qRT-PCR.    
The increased expression of PEDF in Btc transgenic mice during AP could not be 
confirmed by Western blot analysis. Nevertheless, PEDF seems to play a role in 
AP in general, as it is increased in animals with AP. CBG, in contrast, is increased 
in the pancreas of Btc transgenic mice with and without AP. The physiological 
role of CBG is the transport of cortisol and its release in inflamed areas upon its 
cleavage by elastase (Hammond, 1990). In patients with a decreased CBG level 
within the initial 48 hours of AP, CBG was an early predictor of later infected 
pancreatic necrosis (Muller, 2007). Infected pancreatic necrosis is a serious 
complication that worsens prognosis in AP in human patients (Wronski, 2014). 
Endogenous cortisol might play a basic role in the course of AP and in the process 
of later infection (Muller, 2007).  Thus, by increasing the levels of CBG in the 
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pancreas of transgenic mice, BTC may protect these mice against AP by 
promoting the anti-inflammatory effect of cortisol (Hammond, 1990).  
To learn more about the role of CBG and cortisol in AP, it would be interesting to 
create and investigate mice with pancreas-specific overexpression of CBG. By 
employing the caerulein pancreatitis model it would be possible to figure out if 
these mice are protected against AP. Additionally, cortisol could be measured in 
the acinar cells of CBG-overexpressing mice with caerulein-induced pancreatitis 
to establish a relationship between CBG, cortisol and the protection against AP.
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VI. ZUSAMMENFASSUNG 
In dieser Arbeit wurde der protektive Effekt von BTC bei akuter Pankreatitis 
näher untersucht. In vorherigen Studien konnte nachgewiesen werden, dass 
Mäuse, die BTC ubiquitär überexprimieren vor akuter induzierter Pankreatitis 
geschützt sind. Btc-transgene Tiere zeigen außerdem ein signifikant reduziertes 
Pankreasgewicht, welches nicht über den EGF-Rezeptor vermittelt wird. Da der 
EGFR und der ERBB4-Rezeptor die einzigen Rezeptoren der ERBB-Familie sind, 
die durch BTC als Homodimere aktiviert werden können, wurden diese 
Rezeptoren in Mausmodellen untersucht, um die Rolle dieser Rezeptoren im 
exokrinen Pankreas und während der akuten Pankreatitis im Zusammenspiel mit 
ihrem Liganden BTC näher bestimmen zu können. 
Zuerst konnte an einem EGFR-Knockdown-Mausmodell, mit zusätzlicher 
ubiquitären BTC-Überexprimierung, nachgewiesen werden, dass der protektive 
Effekt von BTC nicht EGFR vermittelt ist, da auch diese Tiere vor akuter 
Pankreatitis geschützt sind. 
Mithilfe eines konditionalen ERBB4-Knockoutmodels konnte die Rolle von 
ERBB4 im exokrinen Pankreas untersucht werden und zudem, ob die 
Entwicklung der Maus durch den Verlust von ERBB4 im Pankreas beeinflusst 
wird. Der Verlust von ERBB4 im exokrinen Pankreas hatte keinen 
offensichtlichen Einfluss auf die Entwicklung der Maus oder auf das exokrine 
Pankreas. Auch der Verlauf der akuten induzierten Pankreatitis wurde nicht vom 
Verlust des ERBB4-Rezeptors beeinflusst. Jedoch konnte nach zusätzlicher BTC-
Überexprimierung gezeigt werden, dass Btc-transgene Mäuse nicht mehr vor 
akuter Pankreatitis geschützt sind. Das zeigt, dass der protektive Effekt von BTC 
über ERBB4 vermittelt wird. 
Um einen möglichen molekularbiologischen Mechansimus zu finden, der für den 
protektiven Effekt bei den Btc-transgenen Tieren verantwortlich ist, wurden 
verschiedene mögliche Signalkaskaden wie SAPK, MAPK und AKT näher 
untersucht. Der SAPK-Signalweg scheint durch die BTC-Überexpression 
verstärkt aktiviert zu werden. Außerdem konnte der ERBB4-Rezeptor selbst in 
verschiedenen Zellfraktionen des Pankreas nachgewiesen werden. Sowohl in der 
Membran als auch im Zytoplasma und im Zellkern konnte der Rezeptor detektiert 
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werden. Nach der Aktivierung von ERBB4 kann außerdem der zytoplasmatische 
Teil des ERBB4-Rezeptors, durch eine γ-Sekretase, abgespalten werden. Diese 
120 kDa große Domäne des ERBB4-Rezeptors wurde verstärkt im Zytoplasma 
und zu einem geringen Anteil im Zellkern von Btc-transgenen Mäusen 
nachgewiesen. Aus der Literatur ist bekannt, dass die 120 kDa große intrazelluläre 
Domäne (ICD) in der Lage ist als Transkriptionsfaktor zu agieren. Durch die ICD 
kann die Expression verschiedener Gene direkt und indirekt beeinflusst werden.  
Um mögliche Gene zu identifizieren, die protektiv in der Pankreatitis wirken, 
wurden Microarrays von Pankreasproben von Btc-transgenen Mäusen mit und 
ohne akuter Pankretitis durchgeführt. In den Microarrays wurde festgestellt, dass 
unter anderem Cbg während der akuten Pankreatitis bei Btc-transgenen Mäusen 
hochreguliert ist. Auch auf Proteinebene konnte eine stärkere Expression von 
CBG in Pankreas von Btc-transgenen Mäusen mit und ohne akuter Pankreatitis 
nachgewiesen werden. Das könnte auf eine mögliche Beteiligung von CBG am 
Schutz vor akuter Pankreatitis hinweisen. Ob die vermehrte Expression von CBG 
durch die Bindung von BTC an den ERBB4-Rezeptor ausgelöst wird, muss in 
weiteren Studien herausgefunden werden.  
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VII. SUMMARY 
In this study the protective effect of BTC in AP was examined. Previous studies 
established that BTC protects mice against AP. Furthermore Btc transgenic mice 
show a significantly reduced pancreas weight, which is not mediated by the 
EGFR. Since EGFR and ERBB4 are the two homodimers which can be activated 
by BTC, different mouse models were examined in order to determine the role of 
the receptors in the exocrine pancreas and in AP in interaction with their ligand 
BTC.  
In the EGFR knockdown model with an additional ubiquitous BTC-
overexpression it could be confirmed that the protective effect of BTC is not 
mediated by EGFR, as these animals are still protected against induced AP. 
The role of ERBB4 in the exocrine pancreas was investigated using a conditional 
ERBB4 knockout model. With this knockout model it was possible to figure out if 
the development of the mouse is influenced by the loss of ERBB4 in the exocrine 
pancreas. The loss of pancreatic ERBB4 did not affect the development of the 
mouse or the development of the exocrine pancreas. Even the course of AP was 
not modified by the loss of ERBB4. However, conditional ERBB4 knockout mice 
with additional BTC-overexpression, in contrast to Btc transgenic mice, are no 
longer protected against AP. Based on these findings it could be demonstrated that 
the protective effect caused by overexpressed BTC is ERBB4-dependent. 
To find signal cascades which are triggered by the binding of BTC to the ERBB4 
receptor, several pathways such as SAPK, MAPK and AKT were examined. It 
turned out that the SAPK pathway seems to be activated by this binding. In 
addition, the ERBB4 receptor itself could be detected in all examined cell 
fractions: the membrane, the cytoplasm and the nucleus. After activation the 
ERBB4 receptor can be cleaved and a 120 kDa domain (ICD) is released into the 
cytoplasm. This ICD showed an enhanced detection in the cytoplasm and a slight 
detection in the nucleus of mice overexpressing BTC. These results indicate that 
the 120 kDa domain of the ERBB4 receptor is known to act as transcription factor 
and thereby affect directly and indirectly the expression of different genes.  
In order to detect these genes a microarray analysis was performed with 
pancreatic samples of Btc transgenic mice with and without AP. In the microarray 
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analysis, Cbg was detected to be upregulated in AP of Btc transgenic mice. CBG 
protein levels were also higher in the pancreas of Btc transgenic with and without 
pancreatitis, indicating an involvement of CBG in the protection against AP 
triggered by BTC. Further studies are needed to reveal whether the upregulation 
of CBG results from the activation of ERBB4 via BTC. 
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